Fidelity Commonwealth Trust

07/23/2026 | Press release | Distributed by Public on 07/23/2026 08:46

Semi-Annual Report by Investment Company (Form N-CSRS)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM N-CSR

CERTIFIED SHAREHOLDER REPORT OF REGISTERED

MANAGEMENT INVESTMENT COMPANIES

Investment Company Act file number 811-02546

Fidelity Commonwealth Trust

(Exact name of registrant as specified in charter)

245 Summer St., Boston, MA 02210

(Address of principal executive offices) (Zip code)

Nicole Macarchuk, Secretary

245 Summer St.

Boston, Massachusetts 02210

(Name and address of agent for service)

Registrant's telephone number, including area code:

617-563-7000

Date of fiscal year end:

November 30

Date of reporting period:

May 31, 2026

Item 1.

Reports to Stockholders

SEMI-ANNUAL SHAREHOLDER REPORT | AS OF MAY 31, 2026
Fidelity® Nasdaq Composite Index® ETF
Fidelity® Nasdaq Composite Index® ETF : ONEQ
Principal U.S. Listing Exchange : NASDAQ/NMS Global Market
This semi-annual shareholder report contains information about Fidelity® Nasdaq Composite Index® ETF for the period December 1, 2025 to May 31, 2026. You can find additional information about the Fund at fundresearch.fidelity.com/prospectus/sec. You can also request this information by contacting us at 1-800-FIDELITY or by sending an e-mail to [email protected].
What were your Fund costs for the last six months?
(based on hypothetical $10,000 investment)
Costs of a $10,000 investment
Costs paid as a percentage of a $10,000 investment
Fidelity® Nasdaq Composite Index® ETF
$ 11
0.21%
Key Fund Statistics
(as of May 31, 2026)
KEY FACTS
Fund Size
$10,922,502,914
Number of Holdings
1,025
Portfolio Turnover
6%
What did the Fund invest in?
(as of May 31, 2026)
MARKET SECTORS
(% of Fund's net assets)
Information Technology
54.0
Communication Services
14.8
Consumer Discretionary
12.8
Health Care
4.6
Consumer Staples
4.4
Industrials
3.3
Financials
2.9
Materials
0.9
Utilities
0.8
Real Estate
0.5
Energy
0.5
ASSET ALLOCATION (% of Fund's net assets)
Common Stocks - 99.5
Short-Term Investments and Net Other Assets (Liabilities) - 0.5
GEOGRAPHIC DIVERSIFICATION (% of Fund's net assets)
United States - 97.1
Netherlands - 0.8
Canada - 0.6
Israel - 0.4
China - 0.4
Brazil - 0.3
United Kingdom - 0.1
Switzerland - 0.1
Kazakhstan - 0.1
Others - 0.1
TOP HOLDINGS
(% of Fund's net assets)
NVIDIA Corp
11.3
Apple Inc
10.0
Microsoft Corp
7.4
Amazon.com Inc
6.4
Alphabet Inc Class A
4.9
Broadcom Inc
4.7
Alphabet Inc Class C
4.5
Tesla Inc
3.6
Meta Platforms Inc Class A
3.1
Micron Technology Inc
2.5
58.4
Fidelity, the Fidelity Investments Logo and all other Fidelity trademarks or service marks used herein are trademarks or service marks of FMR LLC. Any third-party marks that are used herein are trademarks or service marks of their respective owners. © 2026 FMR LLC. All rights reserved.
For additional information about the Fund; including its prospectus, financial information, holdings and proxy information, scan the QR code or visit fundresearch.fidelity.com/prospectus/sec
1.9915910.102 1283-TSRS-0726

Item 2.

Code of Ethics

Not applicable.

Item 3.

Audit Committee Financial Expert

Not applicable.

Item 4.

Principal Accountant Fees and Services

Not applicable.

Item 5.

Audit Committee of Listed Registrants

Not applicable.

Item 6.

Investments

(a)

Not applicable.

(b)

Not applicable

Item 7.

Financial Statements and Financial Highlights for Open-End Management Investment Companies

Fidelity® Nasdaq Composite Index® ETF
Semi-Annual Report
May 31, 2026

Contents

Item 7: Financial Statements and Financial Highlights for Open-End Management Investment Companies (Semi-Annual Report)

Fidelity® Nasdaq Composite Index® ETF

Notes to Financial Statements

Item 8: Changes in and Disagreements with Accountants for Open-End Management Investment Companies

Item 9: Proxy Disclosures for Open-End Management Investment Companies

Item 10: Remuneration Paid to Directors, Officers, and others of Open-End Management Investment Companies

Item 11: Statement Regarding Basis for Approval of Investment Advisory Contract

To view a fund's proxy voting guidelines and proxy voting record for the 12-month period ended June 30, visit http://www.fidelity.com/proxyvotingresults or visit the Securities and Exchange Commission's (SEC) web site at http://www.sec.gov.
You may also call 1-800-FIDELITY to request a free copy of the proxy voting guidelines.
"Nasdaq®, Nasdaq Composite Index®, Nasdaq Composite®, and The Nasdaq Stock Market®, are registered trademarks of Nasdaq, Inc. (which with its affiliates is referred to as the "Corporations") and are licensed for use by Fidelity. The Product(s) have not been passed on by the Corporations as to their legality or suitability. The Product(s) are not issued, endorsed, sold, or promoted by the Corporations. The Corporations make no warranties and bear no liability with respect to the products(s).
The index is a product of S&P Dow Jones Indices LLC or its affiliates ("SPDJI") and has been licensed for us by Fidelity. S&P®;, S&P 500®, US 500, The 500, iBoxx®, iTraxx® and CDX® are trademarks of S&P Global, Inc. or its affiliates ("S&P") and Dow Jones®; is a registered trademark of Dow Jones Trademark Holdings LLC ("Dow Jones"). The fund is not sponsored, endorsed, sold or promoted by SPDJI, Dow Jones, S&P, or their respective affiliates and none of such parties make any representation regarding the advisability of investing in such product(s) nor do they have any liability for any errors, omissions, or interruptions of the index or indices.
Standard & Poor's, S&P and S&P 500 are registered service marks of The McGraw-Hill Companies, Inc. and have been licensed for use by Fidelity Distributors Corporation.
Other third-party marks appearing herein are the property of their respective owners.
All other marks appearing herein are registered or unregistered trademarks or service marks of FMR LLC or an affiliated company. © 2026 FMR LLC. All rights reserved.
This report and the financial statements contained herein are submitted for the general information of the shareholders of the Fund. This report is not authorized for distribution to prospective investors in the Fund unless preceded or accompanied by an effective prospectus.
A fund files its complete schedule of portfolio holdings with the SEC for the first and third quarters of each fiscal year on Form N-PORT. Forms N-PORT are available on the SEC's web site at http://www.sec.gov. A fund's Forms N-PORT may be reviewed and copied at the SEC's Public Reference Room in Washington, DC. Information regarding the operation of the SEC's Public Reference Room may be obtained by calling 1-800-SEC-0330.
For a complete list of a fund's portfolio holdings, view the most recent holdings listing, semiannual report, or annual report on Fidelity's web site at http://www.fidelity.com, http://www.institutional.fidelity.com, or http://www.401k.com, as applicable.
NOT FDIC INSURED •MAY LOSE VALUE •NO BANK GUARANTEE
Neither the Fund nor Fidelity Distributors Corporation is a bank.
Item 7: Financial Statements and Financial Highlights for Open-End Management Investment Companies (Semi-Annual Report)
Fidelity® Nasdaq Composite Index® ETF
Schedule of Investments May 31, 2026 (Unaudited)
Showing Percentage of Net Assets
Common Stocks - 99.5%
Shares
Value ($)
ARGENTINA - 0.0%
Financials - 0.0%
Banks - 0.0%
Grupo Financiero Galicia SA Class B ADR (c)
15,152
768,055
AUSTRALIA - 0.0%
Information Technology - 0.0%
Software - 0.0%
Braiin Ltd (c)
3,562
45,558
IREN Ltd (b)(c)
78,451
4,984,777
TOTAL AUSTRALIA
5,030,335
AUSTRIA - 0.0%
Materials - 0.0%
Metals & Mining - 0.0%
Critical Metals Corp (b)(c)
30,484
341,420
BAHAMAS (NASSAU) - 0.0%
Consumer Discretionary - 0.0%
Diversified Consumer Services - 0.0%
OneSpaWorld Holdings Ltd (c)
36,787
873,691
BELGIUM - 0.0%
Communication Services - 0.0%
Diversified Telecommunication Services - 0.0%
Liberty Global Ltd Class A (b)(c)
67,022
838,445
Liberty Global Ltd Class C (b)(c)
61,150
743,584
TOTAL BELGIUM
1,582,029
BRAZIL - 0.3%
Consumer Discretionary - 0.3%
Broadline Retail - 0.3%
MercadoLibre Inc (b)
12,075
20,474,974
Diversified Consumer Services - 0.0%
Afya Ltd Class A (c)
32,571
456,320
TOTAL CONSUMER DISCRETIONARY
20,931,294
Financials - 0.0%
Banks - 0.0%
Inter & Co Inc Class A (c)
103,964
641,458
Capital Markets - 0.0%
XP Inc Class A
106,058
1,767,987
Financial Services - 0.0%
StoneCo Ltd Class A (c)
71,523
818,938
TOTAL FINANCIALS
3,228,383
Materials - 0.0%
Metals & Mining - 0.0%
Sigma Lithium Corp (United States) (b)(c)
35,694
598,588
TOTAL BRAZIL
24,758,265
CAMEROON - 0.0%
Energy - 0.0%
Oil, Gas & Consumable Fuels - 0.0%
Golar LNG Ltd (c)
25,397
1,263,501
CANADA - 0.6%
Health Care - 0.0%
Biotechnology - 0.0%
Aurinia Pharmaceuticals Inc (b)
44,730
685,711
Xenon Pharmaceuticals Inc (b)
23,963
1,311,495
1,997,206
Life Sciences Tools & Services - 0.0%
AbCellera Biologics Inc (b)(c)
134,674
830,939
Pharmaceuticals - 0.0%
Cronos Group Inc (United States) (b)
216,657
615,306
Tilray Brands Inc Class 2 (b)(c)
34,558
190,414
805,720
TOTAL HEALTH CARE
3,633,865
Industrials - 0.1%
Professional Services - 0.1%
Thomson Reuters Corp (United States) (c)
104,985
9,082,252
Information Technology - 0.4%
IT Services - 0.4%
Shopify Inc Class A (United States) (b)
291,797
34,639,222
Semiconductors & Semiconductor Equipment - 0.0%
Canadian Solar Inc (b)(c)
4,790
90,962
Software - 0.0%
Descartes Systems Group Inc/The (United States) (b)(c)
24,740
1,825,070
Open Text Corp (United States) (c)
62,669
1,494,029
3,319,099
TOTAL INFORMATION TECHNOLOGY
38,049,283
Materials - 0.1%
Chemicals - 0.0%
Methanex Corp (United States)
24,350
1,439,085
Metals & Mining - 0.1%
Almonty Industries Inc (United States) (b)
70,316
1,382,413
Elemental Royalty Corp (United States)
31,594
563,636
Ssr Mining Inc (United States) (b)
53,014
1,655,097
Tmc The Metals CO Inc Class A (b)(c)
118,537
717,149
4,318,295
TOTAL MATERIALS
5,757,380
Real Estate - 0.0%
Real Estate Management & Development - 0.0%
Colliers International Group Inc Subordinate Voting Shares (United States) (c)
14,698
1,386,903
FirstService Corp Subordinate Voting Shares (United States) (c)
13,108
1,759,094
TOTAL REAL ESTATE
3,145,997
TOTAL CANADA
59,668,777
CHINA - 0.4%
Communication Services - 0.1%
Entertainment - 0.0%
Netease Inc ADR
21,961
2,697,250
Interactive Media & Services - 0.1%
Baidu Inc Class A ADR (b)(c)
28,352
3,836,309
Bilibili Inc ADR (b)(c)
31,909
552,664
JOYY Inc Class A ADR
17,899
1,206,930
5,595,903
TOTAL COMMUNICATION SERVICES
8,293,153
Consumer Discretionary - 0.3%
Automobile Components - 0.0%
WeRide Inc ADR (b)(c)
73,017
551,278
Automobiles - 0.0%
Li Auto Inc ADR (b)(c)
58,998
885,560
Broadline Retail - 0.2%
JD.com Inc ADR
115,926
3,342,147
PDD Holdings Inc Class A ADR (b)
157,859
13,329,614
16,671,761
Hotels, Restaurants & Leisure - 0.1%
Atour Lifestyle Holdings Ltd ADR
31,795
1,091,840
H World Group Ltd ADR
36,058
1,618,644
Trip.com Group Ltd ADR (b)
60,616
2,875,017
5,585,501
TOTAL CONSUMER DISCRETIONARY
23,694,100
Financials - 0.0%
Consumer Finance - 0.0%
Qfin Holdings Inc Class A ADR
34,716
558,233
Insurance - 0.0%
Maase Inc Class A (b)(c)
3,268
38,857
TOTAL FINANCIALS
597,090
Health Care - 0.0%
Pharmaceuticals - 0.0%
BGM Group Ltd Class A (b)(c)
61,739
19,583
Industrials - 0.0%
Professional Services - 0.0%
Kanzhun Ltd ADR
90,909
1,233,635
Information Technology - 0.0%
IT Services - 0.0%
GDS Holdings Ltd Class A ADR (b)(c)
25,649
909,257
Vnet Group Inc Class A ADR (b)(c)
47,998
483,820
TOTAL INFORMATION TECHNOLOGY
1,393,077
TOTAL CHINA
35,230,638
COSTA RICA - 0.0%
Health Care - 0.0%
Health Care Equipment & Supplies - 0.0%
Establishment Labs Holdings Inc (b)(c)
9,685
684,633
DENMARK - 0.0%
Health Care - 0.0%
Biotechnology - 0.0%
Ascendis Pharma A/S (b)
14,549
3,260,577
Genmab A/S ADR (b)
25,967
683,711
TOTAL DENMARK
3,944,288
FRANCE - 0.0%
Communication Services - 0.0%
Media - 0.0%
Criteo SA ADR (b)
30,117
549,635
Health Care - 0.0%
Biotechnology - 0.0%
Abivax SA ADR (b)
14,583
1,934,144
Clementia Pharmaceuticals Inc rights (b)(d)
20,215
0
TOTAL HEALTH CARE
1,934,144
TOTAL FRANCE
2,483,779
GERMANY - 0.0%
Health Care - 0.0%
Biotechnology - 0.0%
BioNTech SE ADR (b)
28,414
2,726,324
Immatics NV (b)(c)
60,449
695,768
3,422,092
Pharmaceuticals - 0.0%
AtaiBeckley Inc (b)(c)
112,544
509,824
TOTAL GERMANY
3,931,916
GRAND CAYMAN (UK OVERSEAS TER) - 0.0%
Financials - 0.0%
Capital Markets - 0.0%
Webull Corp Class A (b)(c)
107,440
687,616
Insurance - 0.0%
Oxbridge Re Holdings Ltd (b)(c)
92,193
94,959
TOTAL GRAND CAYMAN (UK OVERSEAS TER)
782,575
GREECE - 0.0%
Industrials - 0.0%
Marine Transportation - 0.0%
Star Bulk Carriers Corp
41,328
1,126,188
GUATEMALA - 0.0%
Communication Services - 0.0%
Wireless Telecommunication Services - 0.0%
Millicom International Cellular SA (c)
41,730
3,562,073
HONG KONG - 0.1%
Communication Services - 0.0%
Media - 0.0%
QMMM Holdings Ltd Class A (b)(d)
11,212
669,356
Consumer Discretionary - 0.0%
Hotels, Restaurants & Leisure - 0.0%
Melco Resorts & Entertainment Ltd ADR (b)
71,874
399,619
Financials - 0.0%
Capital Markets - 0.0%
Futu Holdings Ltd Class A ADR
19,226
2,000,850
Health Care - 0.1%
Pharmaceuticals - 0.1%
Regencell Bioscience Holdings Ltd (b)(c)
120,879
2,889,009
Information Technology - 0.0%
IT Services - 0.0%
Mega Fortune Co Ltd (b)(c)
4,084
338,890
TOTAL HONG KONG
6,297,724
INDIA - 0.0%
Consumer Discretionary - 0.0%
Hotels, Restaurants & Leisure - 0.0%
MakeMyTrip Ltd (b)(c)
21,691
1,013,837
INDONESIA - 0.0%
Consumer Discretionary - 0.0%
Distributors - 0.0%
Polibeli Group Ltd Class A (c)
90,626
638,007
IRELAND - 0.0%
Industrials - 0.0%
Commercial Services & Supplies - 0.0%
Cimpress PLC (b)(c)
9,079
894,826
ISRAEL - 0.4%
Consumer Discretionary - 0.0%
Automobile Components - 0.0%
Mobileye Global Inc Class A (b)
64,626
668,233
Broadline Retail - 0.0%
Global-e Online Ltd (b)
43,552
1,334,433
TOTAL CONSUMER DISCRETIONARY
2,002,666
Financials - 0.0%
Capital Markets - 0.0%
Etoro Group Ltd Class A (b)
23,994
1,007,268
Industrials - 0.1%
Aerospace & Defense - 0.1%
Elbit Systems Ltd (United States) (c)
11,247
9,907,370
Information Technology - 0.3%
Communications Equipment - 0.0%
Gilat Satellite Networks Ltd (United States) (b)(c)
28,159
483,490
Electronic Equipment, Instruments & Components - 0.0%
Nayax Ltd (United States) (b)(c)
14,231
1,078,852
IT Services - 0.0%
Matrix IT Ltd
13,785
434,940
Wix.com Ltd (b)(c)
13,950
782,037
1,216,977
Semiconductors & Semiconductor Equipment - 0.2%
Camtek Ltd/Israel (b)(c)
9,260
1,589,572
Nova Ltd (b)(c)
7,518
3,776,517
Tower Semiconductor Ltd (United States) (b)
26,225
6,693,407
12,059,496
Software - 0.1%
Cellebrite DI Ltd (b)
83,173
1,225,138
Check Point Software Technologies Ltd (b)
25,625
3,460,657
Nice Ltd ADR (b)(c)
12,284
1,138,235
Radware Ltd (b)
23,068
699,883
6,523,913
TOTAL INFORMATION TECHNOLOGY
21,362,728
Utilities - 0.0%
Independent Power and Renewable Electricity Producers - 0.0%
Enlight Renewable Energy Ltd (United States) (b)(c)
35,608
3,825,011
TOTAL ISRAEL
38,105,043
ITALY - 0.0%
Industrials - 0.0%
Passenger Airlines - 0.0%
Ryanair Holdings PLC ADR
53,188
3,232,767
JAPAN - 0.0%
Health Care - 0.0%
Pharmaceuticals - 0.0%
Satsuma Pharmaceuticals Inc rights (b)(d)
218,164
1
Information Technology - 0.0%
Semiconductors & Semiconductor Equipment - 0.0%
Allegro MicroSystems Inc (b)(c)
35,582
1,703,311
TOTAL JAPAN
1,703,312
JORDAN - 0.0%
Financials - 0.0%
Insurance - 0.0%
International General Insurance Holdings Ltd (c)
17,074
416,775
KAZAKHSTAN - 0.1%
Financials - 0.1%
Capital Markets - 0.0%
Freedom Holding Corp/NV (b)(c)
16,847
2,406,089
Consumer Finance - 0.1%
Kaspi.KZ JSC ADR
49,286
4,455,454
TOTAL KAZAKHSTAN
6,861,543
KOREA (SOUTH) - 0.0%
Communication Services - 0.0%
Interactive Media & Services - 0.0%
Webtoon Entertainment Inc (b)(c)
61,661
757,814
LUXEMBOURG - 0.0%
Health Care - 0.0%
Biotechnology - 0.0%
Alvotech SA (b)(c)
131,339
441,299
MOROCCO - 0.0%
Materials - 0.0%
Metals & Mining - 0.0%
Aya Gold & Silver Inc (United States) (b)(c)
34,021
714,441
NETHERLANDS - 0.8%
Health Care - 0.1%
Biotechnology - 0.1%
Argenx SE ADR (b)
6,601
5,518,370
Newamsterdam Pharma Co NV (b)(c)
34,423
1,159,367
uniQure NV (b)(c)
17,365
495,423
7,173,160
Pharmaceuticals - 0.0%
Pharvaris NV (b)(c)
26,840
809,494
TOTAL HEALTH CARE
7,982,654
Information Technology - 0.7%
Semiconductors & Semiconductor Equipment - 0.6%
ASML Holding NV depository receipt
20,699
33,382,520
NXP Semiconductors NV
58,588
18,827,254
52,209,774
Software - 0.1%
Nebius Group NV Class A (b)(c)
52,281
12,081,616
TOTAL INFORMATION TECHNOLOGY
64,291,390
TOTAL NETHERLANDS
72,274,044
PAKISTAN - 0.0%
Communication Services - 0.0%
Wireless Telecommunication Services - 0.0%
VEON Ltd ADR (b)
13,463
755,813
PUERTO RICO - 0.0%
Communication Services - 0.0%
Diversified Telecommunication Services - 0.0%
Liberty Latin America Ltd Class C (b)
77,014
631,515
Financials - 0.0%
Banks - 0.0%
Popular Inc
16,732
2,485,204
TOTAL PUERTO RICO
3,116,719
RUSSIA - 0.0%
Consumer Discretionary - 0.0%
Broadline Retail - 0.0%
Ozon Holdings PLC ADR (b)(c)(d)
22,100
0
SINGAPORE - 0.0%
Industrials - 0.0%
Ground Transportation - 0.0%
Grab Holdings Ltd Class A (b)
932,217
3,300,048
Information Technology - 0.0%
Semiconductors & Semiconductor Equipment - 0.0%
Kulicke & Soffa Industries Inc
8,352
850,985
TOTAL SINGAPORE
4,151,033
SOUTH AFRICA - 0.0%
Information Technology - 0.0%
Software - 0.0%
Karooooo Ltd
13,855
660,884
SWEDEN - 0.0%
Health Care - 0.0%
Pharmaceuticals - 0.0%
Dova Pharmaceuticals Inc rights (b)(d)
7,729
0
Information Technology - 0.0%
Communications Equipment - 0.0%
Telefonaktiebolaget LM Ericsson Class B ADR (c)
82,325
1,075,165
TOTAL SWEDEN
1,075,165
SWITZERLAND - 0.1%
Consumer Discretionary - 0.0%
Automobile Components - 0.0%
Garrett Motion Inc
46,131
1,511,252
Energy - 0.0%
Oil, Gas & Consumable Fuels - 0.0%
TORM PLC Class A (United States)
36,393
991,345
Health Care - 0.0%
Biotechnology - 0.0%
CRISPR Therapeutics AG (b)(c)
27,615
1,551,411
Health Care Technology - 0.0%
Sophia Genetics SA (b)
56,984
287,769
Pharmaceuticals - 0.0%
Oculis Holding AG (b)(c)
24,995
574,385
TOTAL HEALTH CARE
2,413,565
Information Technology - 0.1%
Technology Hardware, Storage & Peripherals - 0.1%
Logitech International SA (United States) (c)
35,751
4,356,974
TOTAL SWITZERLAND
9,273,136
TAIWAN - 0.0%
Financials - 0.0%
Financial Services - 0.0%
OBOOK Holdings Inc Class A (c)
14,479
83,978
Health Care - 0.0%
Biotechnology - 0.0%
Jyong Biotech Ltd (b)(c)
26,558
58,427
YD Bio Ltd (c)
22,725
68,630
TOTAL HEALTH CARE
127,057
Information Technology - 0.0%
Semiconductors & Semiconductor Equipment - 0.0%
Himax Technologies Inc ADR
22,377
460,295
Silicon Motion Technology Corp ADR
5,480
1,517,248
TOTAL INFORMATION TECHNOLOGY
1,977,543
TOTAL TAIWAN
2,188,578
UNITED ARAB EMIRATES - 0.0%
Communication Services - 0.0%
Wireless Telecommunication Services - 0.0%
Kyivstar Group Ltd (c)
72,918
1,041,269
UNITED KINGDOM - 0.1%
Communication Services - 0.0%
Wireless Telecommunication Services - 0.0%
Vodafone Group PLC ADR
92,033
1,376,814
Consumer Staples - 0.1%
Beverages - 0.1%
Coca-Cola Europacific Partners PLC
108,559
9,845,216
Financials - 0.0%
Capital Markets - 0.0%
Marex Group PLC (c)
21,997
1,164,521
Financial Services - 0.0%
Wise Group PLC (c)
242,775
3,100,237
TOTAL FINANCIALS
4,264,758
Health Care - 0.0%
Biotechnology - 0.0%
Immunocore Holdings PLC ADR (b)
19,801
572,051
Pharmaceuticals - 0.0%
Astrazeneca PLC rights (b)(d)
21,510
0
CinCor Pharma Inc rights (b)(d)
12,042
0
0
TOTAL HEALTH CARE
572,051
TOTAL UNITED KINGDOM
16,058,839
UNITED STATES - 96.6%
Communication Services - 14.7%
Diversified Telecommunication Services - 0.3%
AST SpaceMobile Inc Class A (b)(c)
67,124
7,612,533
Cogent Communications Holdings Inc (c)
19,371
344,029
Comcast Corp Class A
842,660
20,956,954
GCI LLC Class C
15,574
348,390
Globalstar Inc (b)
31,347
2,639,731
Iridium Communications Inc (c)
35,935
1,860,714
Shenandoah Telecommunications Co (c)
39,390
628,271
Uniti Group Inc (b)
79,325
890,027
35,280,649
Entertainment - 1.2%
Atlanta Braves Holdings Inc Class C (b)(c)
19,757
979,947
Electronic Arts Inc
58,021
11,703,996
Liberty Media Corp-Liberty Formula One Class A (b)(c)
9,456
794,115
Liberty Media Corp-Liberty Formula One Class C (b)
51,070
4,636,645
Netflix Inc (b)
1,001,720
86,167,955
Playtika Holding Corp (c)
162,893
614,107
Roku Inc Class A (b)
31,074
4,045,213
Take-Two Interactive Software Inc (b)
44,619
10,001,795
Warner Bros Discovery Inc (b)
584,335
15,782,888
Warner Music Group Corp Class A
42,387
1,336,886
136,063,547
Interactive Media & Services - 12.5%
Alphabet Inc Class A
1,385,722
527,045,506
Alphabet Inc Class C
1,294,317
487,219,748
Cargurus Inc Class A (b)(c)
26,480
790,693
IAC Inc Class A (b)(c)
25,272
1,134,460
Match Group Inc
60,558
2,187,961
Meta Platforms Inc Class A
520,063
328,945,048
Rumble Inc Class A (b)(c)
110,248
1,013,179
Trump Media & Technology Group Corp (b)(c)
91,699
853,718
Ziff Davis Inc (b)(c)
17,263
778,043
ZoomInfo Technologies Inc (b)(c)
95,914
319,393
1,350,287,749
Media - 0.3%
Advantage Solutions Inc Class A (b)(c)
10,473
391,900
Charter Communications Inc Class A (b)(c)
30,622
4,411,099
comScore Inc (b)(c)
13,562
108,766
EchoStar Corp Class A (b)(c)
37,914
4,898,110
Fox Corp Class A
50,824
3,248,670
Fox Corp Class B
50,340
2,889,013
Liberty Broadband Corp Class C (b)
35,899
1,211,950
Magnite Inc (b)
45,459
651,427
News Corp Class A
93,522
2,440,925
News Corp Class B (c)
36,631
1,092,336
Nexstar Media Group Inc (c)
7,879
1,405,850
Paramount Skydance Corp Class B (c)
269,737
2,861,910
Sirius XM Holdings Inc (c)
89,288
2,635,782
Stagwell Inc Class A (b)(c)
109,519
767,728
Trade Desk Inc (The) Class A (b)
104,526
2,253,581
Versant Media Group Inc Class A
34,288
1,479,184
32,748,231
Wireless Telecommunication Services - 0.4%
T-Mobile US Inc
260,628
48,875,569
TOTAL COMMUNICATION SERVICES
1,603,255,745
Consumer Discretionary - 12.2%
Automobile Components - 0.1%
Dorman Products Inc (b)(c)
9,788
1,212,929
Gentex Corp
56,420
1,363,107
Goodyear Tire & Rubber Co/The (b)
99,366
606,133
Kodiak AI Inc (b)(c)
66,679
469,419
Patrick Industries Inc (c)
10,223
925,386
QuantumScape Corp Class A (b)(c)
134,369
1,206,634
Visteon Corp (c)
9,702
1,147,650
6,931,258
Automobiles - 3.6%
Cenntro Inc (b)(c)
15,776
70,992
Lucid Group Inc (b)(c)
97,675
639,771
Rivian Automotive Inc Class A (b)(c)
296,396
4,831,255
Tesla Inc (b)
892,232
388,825,783
394,367,801
Broadline Retail - 6.5%
Amazon.com Inc (b)
2,555,322
691,572,346
eBay Inc
107,290
11,723,578
Ollie's Bargain Outlet Holdings Inc (b)(c)
16,116
1,315,549
Pattern Group Inc Class A
50,835
955,190
705,566,663
Distributors - 0.0%
GigaCloud Technology Inc Class A (b)(c)
10,513
378,889
LKQ Corp
70,570
1,913,858
Pool Corp
9,155
1,660,717
3,953,464
Diversified Consumer Services - 0.1%
Driven Brands Holdings Inc (b)
58,743
813,003
Duolingo Inc Class A (b)(c)
9,224
1,027,185
Frontdoor Inc (b)
18,819
1,168,095
Grand Canyon Education Inc (b)
8,535
1,278,970
Laureate Education Inc (b)
39,550
1,265,205
Liberty Live Holdings Inc Class A
5,841
562,605
Liberty Live Holdings Inc Class C
13,837
1,371,247
Lincoln Educational Services Corp (b)(c)
15,769
730,420
Perdoceo Education Corp
23,957
775,728
Strategic Education Inc
9,413
722,447
9,714,905
Hotels, Restaurants & Leisure - 1.3%
Airbnb Inc Class A (b)
98,603
13,144,766
Booking Holdings Inc
186,687
31,257,005
Caesars Entertainment Inc (b)
56,487
1,640,947
Cheesecake Factory Inc/The (c)
17,038
1,125,190
Churchill Downs Inc
17,710
1,544,489
Domino's Pizza Inc
7,331
2,276,862
DoorDash Inc Class A (b)
97,509
15,532,209
DraftKings Inc Class A (b)
120,608
2,953,690
Expedia Group Inc Class A (c)
27,793
6,275,381
Marriott International Inc/MD Class A1
62,172
23,351,803
Monarch Casino & Resort Inc
7,486
900,266
Navan Inc Class A (b)
68,210
1,457,648
Papa John's International Inc (c)
13,068
447,056
Penn Entertainment Inc (b)
53,291
1,003,470
Red Rock Resorts Inc Class A (c)
17,856
1,042,433
SHARPLINK INC (b)(c)
50,754
310,107
Sportradar Holding AG Class A (b)(c)
61,781
816,127
Starbucks Corp
268,362
26,610,776
Target Hospitality Corp (b)
37,275
647,094
Texas Roadhouse Inc
15,447
2,790,037
Wendy's Co/The (c)
84,533
650,904
Wingstop Inc (c)
6,929
1,087,576
Wynn Resorts Ltd (c)
25,100
2,540,622
139,406,458
Household Durables - 0.0%
Cavco Industries Inc (b)
2,210
1,185,710
LGI Homes Inc (b)(c)
10,847
518,595
Newell Brands Inc (c)
153,081
520,475
Sonos Inc (b)(c)
45,549
718,763
2,943,543
Leisure Products - 0.0%
BRP Inc Subordinate Voting Shares (United States)
12,394
716,001
Hasbro Inc
30,618
2,638,354
Mattel Inc (b)(c)
80,928
1,209,064
Peloton Interactive Inc Class A (b)(c)
116,101
743,046
5,306,465
Specialty Retail - 0.5%
Academy Sports & Outdoors Inc (c)
21,308
1,125,062
Five Below Inc (b)
11,755
2,672,617
National Vision Holdings Inc (b)
26,513
444,093
Newegg Commerce Inc Class A (b)(c)
5,698
105,812
O'Reilly Automotive Inc (b)
197,608
17,168,183
Petco Health & Wellness Co Inc Class A (b)(c)
116,421
350,427
RealReal Inc/The (b)(c)
35,678
343,936
Ross Stores Inc
75,782
17,560,964
Tractor Supply Co
127,110
4,007,778
Ulta Beauty Inc (b)
10,379
5,281,354
Upbound Group Inc
30,744
590,592
Urban Outfitters Inc (b)
24,288
1,764,523
Winmark Corp (c)
1,507
570,505
51,985,846
Textiles, Apparel & Luxury Goods - 0.1%
Columbia Sportswear Co (c)
18,046
1,194,284
Crocs Inc (b)
13,941
1,654,378
Lululemon Athletica Inc (b)
26,736
3,507,229
Steven Madden Ltd
22,043
957,548
7,313,439
TOTAL CONSUMER DISCRETIONARY
1,327,489,842
Consumer Staples - 4.3%
Beverages - 0.8%
Celsius Holdings Inc (b)
63,396
2,109,185
Coca-Cola Consolidated Inc
13,498
2,338,663
Keurig Dr Pepper Inc
324,148
9,734,164
Monster Beverage Corp (b)
228,641
20,138,699
National Beverage Corp (b)
31,640
1,170,364
PepsiCo Inc
323,225
46,605,814
Vita Coco Co Inc/The (b)(c)
17,525
1,316,653
83,413,542
Consumer Staples Distribution & Retail - 3.1%
Andersons Inc/The (c)
12,448
878,704
Casey's General Stores Inc
8,899
6,826,779
Chefs' Warehouse Inc/The (b)(c)
14,444
1,105,544
Costco Wholesale Corp
105,337
100,735,880
Dollar Tree Inc (b)
48,234
5,616,367
Ingles Markets Inc Class A (c)
6,851
606,039
Maplebear Inc (b)(c)
63,911
2,543,658
PriceSmart Inc
9,363
1,591,616
Sprouts Farmers Market Inc (b)
23,637
1,952,889
Walmart Inc
1,895,194
219,368,706
341,226,182
Food Products - 0.3%
Bridgford Foods Corp (b)
3,010
23,327
Cal-Maine Foods Inc (c)
13,305
994,150
Campbell's Company/The (c)
77,675
1,639,719
Freshpet Inc (b)
15,286
788,758
J & J Snack Foods Corp
8,507
647,553
Kraft Heinz Co/The
294,845
7,079,228
Marzetti Company/The
8,735
977,796
Mondelez International Inc
302,642
18,512,611
Pilgrim's Pride Corp
65,416
1,851,927
Simply Good Foods Co/The (b)
40,906
471,237
Smithfield Foods Inc
104,617
2,702,257
35,688,563
Household Products - 0.1%
Central Garden & Pet Co Class A (b)
21,947
749,051
Kimberly-Clark Corp (c)
76,155
7,432,729
Reynolds Consumer Products Inc
64,723
1,402,547
WD-40 Co
4,557
911,263
10,495,590
Personal Care Products - 0.0%
Interparfums Inc (c)
9,074
856,313
Olaplex Holdings Inc (b)
364,221
743,011
1,599,324
TOTAL CONSUMER STAPLES
472,423,201
Energy - 0.5%
Energy Equipment & Services - 0.2%
Baker Hughes Co Class A
230,132
14,700,832
National Energy Services Reunited Corp (b)
26,746
651,265
Patterson-UTI Energy Inc
119,664
1,341,433
ProFrac Holding Corp Class A (b)(c)
79,353
484,847
Smart Sand Inc
76,618
328,691
Weatherford International PLC
14,750
1,528,690
19,035,758
Oil, Gas & Consumable Fuels - 0.3%
Alliance Resource Partners LP
42,441
1,054,659
APA Corp
84,725
3,086,532
Calumet Inc (b)
22,571
800,593
Chord Energy Corp
15,989
2,108,469
Diamondback Energy Inc
67,127
12,853,479
Expand Energy Corp
57,226
5,320,873
Green Plains Inc (b)
28,711
449,901
HighPeak Energy Inc Class A (c)
65,632
465,987
NextDecade Corp (b)(c)
96,362
762,223
Plains All American Pipeline LP
155,627
3,490,714
Plains GP Holdings LP Class A
52,525
1,278,984
Viper Energy Inc Class A
40,224
1,830,192
33,502,606
TOTAL ENERGY
52,538,364
Financials - 2.8%
Banks - 0.9%
1st Source Corp
10,504
775,405
Amalgamated Financial Corp
14,961
620,582
BancFirst Corp
10,810
1,192,235
Bancorp Inc/The (b)
14,614
806,108
Bank First Corp (c)
4,921
684,117
Bank OZK (c)
25,824
1,249,623
Banner Corp
13,038
847,470
BCB Bancorp Inc
41,310
431,276
BOK Financial Corp
16,896
2,163,364
Broadway Financial Corp/DE (b)
17,535
168,336
Burke & Herbert Financial Services Corp (c)
8,539
543,080
Business First Bancshares Inc
19,087
543,598
Cathay General Bancorp
22,245
1,282,647
Central BanCo Inc (c)
70,485
2,001,774
City Holding Co
5,983
743,747
Columbia Banking System Inc
73,410
2,175,872
Columbia Financial Inc (b)(c)
42,570
856,934
Commerce Bancshares Inc/MO (c)
38,487
2,009,791
Connectone Bancorp Inc
23,529
707,517
CVB Financial Corp (c)
73,266
1,491,696
East West Bancorp Inc
30,035
3,680,489
Eastern Bankshares Inc
71,726
1,415,154
Enterprise Financial Services Corp (c)
14,274
865,147
Fifth Third Bancorp
208,165
10,393,679
First Bancorp/Southern Pines NC (c)
15,381
904,864
First Busey Corp (c)
33,039
904,277
First Citizens BancShares Inc/NC Class A (c)
2,570
5,115,612
First Community Bankshares Inc (c)
12,413
535,124
First Financial Bancorp (c)
33,997
1,045,748
First Financial Bankshares Inc (c)
44,322
1,448,443
First Hawaiian Inc
41,539
1,120,722
First Internet Bancorp (c)
16,664
402,602
First Interstate BancSystem Inc Class A (c)
32,929
1,172,272
First Merchants Corp
22,914
923,434
First Mid Bancshares Inc
13,151
579,302
Fulton Financial Corp
57,450
1,246,091
German American Bancorp Inc
16,356
715,084
Hancock Whitney Corp (c)
21,526
1,466,351
Hope Bancorp Inc
57,067
715,620
Huntington Bancshares Inc/OH
463,563
7,583,892
Independent Bank Corp (c)
15,651
1,237,681
International Bancshares Corp
19,271
1,390,595
Investar Holding Corp
14,573
411,833
Lakeland Financial Corp (c)
11,333
687,120
Mechanics Bancorp Class A (c)
73,383
1,080,198
Mercantile Bank Corp
10,118
536,153
Nbt Bancorp Inc (c)
19,545
903,761
Northwest Bancshares Inc
59,455
841,288
Old National Bancorp/IN (c)
107,037
2,569,958
Pathward Financial Inc (c)
8,579
705,537
Peoples Bancorp Inc/OH (c)
18,179
632,266
QCR Holdings Inc
7,505
691,586
Republic Bancorp Inc/KY Class A
8,624
698,113
S&T Bancorp Inc (c)
16,521
744,932
Seacoast Banking Corp of Florida (c)
32,730
992,046
Simmons First National Corp Class A
49,561
1,063,083
Stock Yards Bancorp Inc
11,665
836,847
Texas Capital Bancshares Inc (b)
13,836
1,376,544
TFS Financial Corp (c)
88,751
1,412,028
Towne Bank/Portsmouth VA (c)
31,241
1,064,381
TriCo Bancshares
14,089
715,721
Trustmark Corp (c)
21,418
945,819
UMB Financial Corp
18,423
2,418,203
United Bankshares Inc/WV (c)
40,717
1,767,525
Univest Financial Corp
16,048
632,933
Valley National Bancorp
112,191
1,544,870
WaFd Inc
27,760
987,146
WesBanco Inc
31,701
1,098,440
Wintrust Financial Corp
17,657
2,652,611
WSFS Financial Corp
17,671
1,262,593
Zions Bancorp NA
32,623
2,037,306
99,468,196
Capital Markets - 1.1%
BGC Group Inc Class A
110,416
1,153,847
Carlyle Group Inc/The
84,849
3,854,690
CME Group Inc Class A
84,846
23,208,776
Coinbase Global Inc Class A (b)
53,039
10,025,962
Galaxy Digital Inc Class A (b)(c)
48,011
1,420,165
Greenpro Capital Corp (b)(c)
79,569
115,375
Hamilton Lane Inc Class A (c)
11,088
966,097
Interactive Brokers Group Inc Class A
103,830
9,030,095
LPL Financial Holdings Inc
18,705
5,120,868
MarketAxess Holdings Inc
8,826
1,147,733
Morningstar Inc
8,849
1,610,695
Nasdaq Inc
132,194
12,230,589
Northern Trust Corp
43,143
7,138,009
Robinhood Markets Inc Class A (b)
185,773
17,518,394
SEI Investments Co
28,069
2,466,704
StepStone Group Inc Class A
24,025
1,184,673
StoneX Group Inc (b)
21,486
2,435,438
T Rowe Price Group Inc
48,436
5,063,015
TPG Inc Class A
36,003
1,532,648
Tradeweb Markets Inc Class A
29,403
2,947,651
Victory Capital Holdings Inc Class A (c)
19,875
1,680,431
Wealthfront Corp (b)(c)
46,055
562,792
112,414,647
Consumer Finance - 0.2%
Credit Acceptance Corp (b)(c)
3,011
1,727,230
Dave Inc Class A (b)(c)
3,256
920,015
Encore Capital Group Inc (b)
9,935
794,105
EZCORP Inc Class A (b)(c)
27,880
870,971
Figure Technology Solutions Inc Class A
42,631
1,507,006
FirstCash Holdings Inc
11,914
2,620,008
Jefferson Capital Inc (c)
28,663
486,984
SLM Corp (c)
54,477
1,205,031
SoFi Technologies Inc Class A (b)(c)
305,646
5,568,870
Upstart Holdings Inc (b)(c)
22,940
775,143
16,475,363
Financial Services - 0.3%
Affirm Holdings Inc Class A (b)
70,290
5,176,859
Cantor Equity Partners IV Inc
34,517
356,906
Chime Financial Inc Class A (b)
90,982
1,692,265
Crane Inflection Point Acquisition Corp III Class A (b)
37,393
385,896
Enact Holdings Inc (c)
41,291
1,725,551
Euronet Worldwide Inc (b)(c)
11,773
853,307
Fiserv Inc (b)
127,913
7,234,759
Flywire Corp (b)(c)
51,082
819,355
Jack Henry & Associates Inc (c)
16,527
2,252,961
M3-Brigade Acquisition V Corp Class A (b)
36,462
394,154
Marqeta Inc Class A (b)
163,599
664,212
Merchants Bancorp/IN (c)
18,200
857,948
NMI Holdings Inc (b)
26,218
941,226
NMP Acquisition Corp Class A
44,929
460,073
Payoneer Global Inc (b)
138,929
722,431
PayPal Holdings Inc
216,422
9,684,885
Remitly Global Inc (b)
60,215
1,205,504
Sezzle Inc (b)(c)
9,334
1,102,812
Silver Pegasus Acquisition Corp
34,136
349,893
Solarius Capital Acquisition Corp Class A
37,606
386,214
37,267,211
Insurance - 0.3%
Arch Capital Group Ltd (b)
81,457
7,277,368
Baldwin Insurance Group Inc/The Class A (b)(c)
27,949
542,770
Brighthouse Financial Inc (b)
13,146
822,282
Cincinnati Financial Corp
35,295
5,556,139
Erie Indemnity Co Class A (c)
11,529
2,456,484
Goosehead Insurance Inc Class A (b)
8,851
304,386
Palomar Hldgs Inc (b)
8,318
890,359
Principal Financial Group Inc (c)
48,858
5,062,666
Selective Insurance Group Inc
18,078
1,564,470
Skyward Specialty Insurance Group Inc (b)(c)
16,294
718,891
Slide Insurance Holdings Inc (b)
40,620
732,379
Tiptree Inc Class A
27,945
509,717
Willis Towers Watson PLC
21,684
5,413,844
31,851,755
Mortgage Real Estate Investment Trusts (REITs) - 0.0%
Adamas Trust Inc
63,226
581,679
AGNC Investment Corp (c)
236,337
2,460,268
3,041,947
TOTAL FINANCIALS
300,519,119
Health Care - 4.4%
Biotechnology - 2.7%
ACADIA Pharmaceuticals Inc (b)
44,472
963,264
ADMA Biologics Inc (b)(c)
63,237
504,631
Agios Pharmaceuticals Inc (b)(c)
25,095
737,793
Alkermes PLC (b)(c)
44,733
1,887,285
Alnylam Pharmaceuticals Inc (b)
31,104
9,392,786
Amgen Inc
127,368
42,896,269
AnaptysBio Inc (b)
8,753
487,280
Annexon Inc (b)(c)
69,949
379,124
Apogee Therapeutics Inc (b)
15,716
1,290,912
Applied Genetic Technologies Corp/DE (b)(c)(d)
14,225
0
Arcutis Biotherapeutics Inc (b)
33,557
720,133
Ardelyx Inc (b)
92,325
557,643
ArriVent Biopharma Inc (b)(c)
22,839
691,337
Arrowhead Pharmaceuticals Inc (b)
33,800
2,633,358
ARS Pharmaceuticals Inc (b)(c)
40,147
364,133
Beam Therapeutics Inc (b)(c)
33,064
1,088,798
BeOne Medicines Ltd ADR (b)
8,103
2,333,016
Bicara Therapeutics Inc (b)
23,032
500,946
BioCryst Pharmaceuticals Inc (b)(c)
80,493
717,193
Biogen Inc (b)
34,117
6,686,932
BioMarin Pharmaceutical Inc (b)
44,256
2,535,426
Bridgebio Pharma Inc (b)
45,958
3,045,177
Capricor Therapeutics Inc (b)(c)
15,068
451,437
Caris Life Sciences Inc (b)(c)
69,602
1,163,745
Carisma Therapeutics Inc rights (b)(d)
449,253
2
Catalyst Pharmaceuticals Inc (b)
36,425
1,137,553
Celcuity Inc (b)(c)
12,162
1,616,087
Celldex Therapeutics Inc (b)(c)
26,307
826,829
Centessa Pharmaceuticals PLC ADR (b)
35,499
1,411,440
CG oncology Inc (b)(c)
21,265
1,324,597
Cogent Biosciences Inc (b)(c)
42,596
1,489,156
Compass Therapeutics Inc (b)(c)
64,580
153,700
Corvus Pharmaceuticals Inc (b)(c)
27,317
339,004
Cullinan Therapeutics Inc (b)
37,131
610,434
Cyclerion Therapeutics Inc (b)(c)
21,200
66,780
Cytokinetics Inc (b)(c)
30,621
2,350,468
Damora Therapeutics Inc (b)(c)
16,469
409,749
Denali Therapeutics Inc (b)(c)
52,052
1,095,174
Design Therapeutics Inc (b)(c)
37,213
389,992
Dianthus Therapeutics Inc (b)
11,461
1,065,988
Disc Medicine Inc (b)(c)
11,918
829,135
Dyne Therapeutics Inc (b)(c)
44,010
850,713
Erasca Inc (b)(c)
76,593
983,454
Exelixis Inc (b)
63,344
3,197,605
First Tracks Biotherapeutics Inc (c)
8,753
139,698
Generate Biomedicines Inc (c)
41,854
549,124
Geron Corp (b)
348,551
435,689
Gilead Sciences Inc
293,347
39,434,637
GRAIL Inc (b)(c)
11,015
789,555
Halozyme Therapeutics Inc (b)
27,367
1,821,000
Ideaya Biosciences Inc (b)
30,205
890,141
ImmunityBio Inc (b)(c)
243,104
1,828,142
Immunome Inc (b)(c)
30,872
673,936
Immunovant Inc (b)(c)
55,075
1,833,998
Incyte Corp (b)
45,501
4,401,767
Inhibrx Biosciences Inc (b)(c)
4,908
510,481
Insmed Inc (b)
51,047
5,457,435
Intellia Therapeutics Inc (b)(c)
40,956
576,251
Ionis Pharmaceuticals Inc (b)(c)
37,353
2,857,505
Iovance Biotherapeutics Inc (b)(c)
125,344
513,910
Jade Biosciences Inc (b)(c)
25,716
541,065
KalVista Pharmaceuticals Inc (b)
30,371
816,069
Kiniksa Pharmaceuticals International Plc Class A (b)
16,948
819,944
Kinnate Biopharma Inc rights (b)(d)
50,749
0
Kodiak Sciences Inc (b)(c)
16,235
595,987
Krystal Biotech Inc (b)(c)
7,086
2,189,787
Kymera Therapeutics Inc (b)(c)
19,514
1,588,830
Legend Biotech Corp ADR (b)
31,602
858,310
Madrigal Pharmaceuticals Inc (b)
5,488
2,729,018
Mineralys Therapeutics Inc (b)(c)
22,197
699,206
Mirati Therapeutics Inc rights (b)(d)
1,147
0
Mirum Pharmaceuticals Inc (b)(c)
14,006
1,421,609
Moderna Inc (b)(c)
95,873
4,524,247
Monte Rosa Therapeutics Inc (b)(c)
22,362
440,755
MoonLake Immunotherapeutics Class A (b)
30,712
589,056
Natera Inc (b)
33,697
7,526,899
Neurocrine Biosciences Inc (b)
22,757
3,602,433
Novavax Inc (b)(c)
53,436
586,193
Nurix Therapeutics Inc (b)(c)
38,496
683,689
Nuvalent Inc Class A (b)
20,339
2,245,222
Ocugen Inc (b)(c)
132,226
182,472
Olema Pharmaceuticals Inc (b)(c)
23,513
310,136
OmniAb Operations Inc $12.5 earnout shares (b)(d)
2,320
1,090
OmniAb Operations Inc $15 earnout shares (b)(d)
2,320
835
ORIC Pharmaceuticals Inc (b)(c)
40,897
345,580
Oruka Therapeutics Inc (b)(c)
16,709
977,978
Palvella Therapeutics Inc (b)(c)
3,843
455,242
Praxis Precision Medicines Inc (b)
6,831
2,390,645
Precigen Inc (b)
126,693
549,848
Protagonist Therapeutics Inc (b)
16,137
1,606,600
PTC Therapeutics Inc (b)
17,796
1,314,235
Recursion Pharmaceuticals Inc Class A (b)(c)
172,547
619,444
Regeneron Pharmaceuticals Inc
24,493
15,057,807
Rein Therapeutics Inc (b)
75,571
83,884
Relay Therapeutics Inc (b)(c)
65,868
925,445
Revolution Medicines Inc (b)(c)
47,297
7,448,332
Rhythm Pharmaceuticals Inc (b)
16,766
1,480,773
Roivant Sciences Ltd (b)
165,359
4,959,116
Sana Biotechnology Inc (b)
92,682
305,851
Sarepta Therapeutics Inc (b)(c)
31,669
565,925
Savara Inc (b)(c)
80,699
419,635
Scholar Rock Holding Corp (b)(c)
29,191
1,439,116
SELLAS Life Sciences Group Inc (b)(c)
64,480
600,309
Sionna Therapeutics Inc (b)(c)
13,843
592,757
Spyre Therapeutics Inc (b)
24,878
1,828,533
Stoke Therapeutics Inc (b)
16,308
504,080
Summit Therapeutics Inc (b)(c)
191,092
3,351,754
Syndax Pharmaceuticals Inc (b)
28,259
553,594
Tango Therapeutics Inc (b)(c)
36,046
792,291
Taysha Gene Therapies Inc (b)(c)
92,844
544,994
TG Therapeutics Inc (b)(c)
39,288
1,490,587
Travere Therapeutics Inc (b)(c)
26,832
1,265,934
Twist Bioscience Corp (b)
20,417
1,365,285
Tyra Biosciences Inc (b)(c)
18,052
603,117
Ultragenyx Pharmaceutical Inc (b)
32,531
778,792
United Therapeutics Corp (b)
10,075
5,609,962
UroGen Pharma Ltd (b)(c)
14,314
402,653
Vaxcyte Inc (b)(c)
36,335
1,867,619
Vera Therapeutics Inc Class A (b)
18,973
673,921
Veracyte Inc (b)(c)
23,387
1,083,754
Vericel Corp (b)(c)
19,468
648,868
Vertex Pharmaceuticals Inc (b)
59,862
26,790,639
Viking Therapeutics Inc (b)
35,206
1,152,644
Vir Biotechnology Inc (b)(c)
66,676
636,089
Viridian Therapeutics Inc (b)(c)
30,258
533,146
Vor BioPharma Inc (b)(c)
13,777
206,242
Xencor Inc (b)(c)
36,139
429,331
Zenas Biopharma Inc (b)(c)
16,937
311,641
Zymeworks Inc (b)(c)
26,839
674,464
294,081,055
Health Care Equipment & Supplies - 0.9%
ABIOMED Inc (b)(d)
10,350
15,629
Align Technology Inc (b)
16,363
2,862,707
Alphatec Holdings Inc (b)
46,904
363,506
AtriCure Inc (b)(c)
19,754
546,593
Axogen Inc (b)
15,255
602,267
Ceribell Inc (b)(c)
23,111
426,398
Cooper Cos Inc/The (b)
42,776
2,618,319
DENTSPLY SIRONA Inc (c)
71,488
748,479
Dexcom Inc (b)
92,312
6,807,087
GE HealthCare Technologies Inc
104,868
6,537,471
ICU Medical Inc (b)(c)
7,760
1,050,626
IDEXX Laboratories Inc (b)
18,528
10,441,084
Insulet Corp (b)
16,026
2,322,808
Intuitive Surgical Inc (b)
83,841
35,602,243
iRhythm Technologies Inc (b)
8,456
963,138
Kestra Medical Technologies Ltd (b)(c)
23,542
500,503
Lantheus Holdings Inc (b)(c)
18,436
1,830,695
LeMaitre Vascular Inc (c)
8,291
784,743
LivaNova PLC (b)
16,679
1,230,910
Masimo Corp (b)
12,127
2,164,063
Medline Inc Class A (c)
193,182
7,062,734
Merit Medical Systems Inc (b)
18,531
1,168,565
MiniMed Group Inc (c)
76,442
920,362
Neogen Corp (b)
82,762
742,375
Novocure Ltd (b)
49,257
839,339
Omnicell Inc (b)
16,549
730,473
Procept Biorobotics Corp (b)(c)
20,575
541,740
Pulse Biosciences Inc (b)(c)
23,757
593,925
QuidelOrtho Corp (b)(c)
23,870
310,787
Tandem Diabetes Care Inc (b)(c)
23,304
400,829
TransMedics Group Inc (b)(c)
8,359
561,725
UFP Technologies Inc (b)(c)
2,957
650,836
92,942,959
Health Care Providers & Services - 0.2%
Acadia Healthcare Co Inc (b)(c)
32,446
752,747
AdaptHealth Corp (b)
57,164
579,071
Addus HomeCare Corp (b)(c)
6,978
639,743
Alignment Healthcare Inc (b)(c)
54,321
832,198
Astrana Health Inc (b)(c)
20,440
768,953
Aveanna Healthcare Holdings Inc (b)
73,754
528,816
Billiontoone Inc Class A (b)
13,106
1,297,363
BrightSpring Health Services Inc (b)
43,764
2,699,364
Clover Health Investments Corp Class A (b)
175,571
698,773
CorVel Corp (b)
18,119
1,118,848
Ensign Group Inc/The
13,128
2,200,909
GeneDx Holdings Corp Class A (b)
7,227
375,732
Guardant Health Inc (b)
30,484
3,953,470
HealthEquity Inc (b)(c)
21,769
1,915,454
Henry Schein Inc (b)
28,198
2,159,403
LifeStance Health Group Inc (b)
137,650
1,061,282
Lumexa Imaging Holdings Inc (c)
30,666
238,581
OPKO Health Inc (b)
449,453
656,201
Option Care Health Inc (b)(c)
39,355
821,339
Privia Health Group Inc (b)(c)
43,519
936,094
Progyny Inc (b)(c)
27,895
712,996
RadNet Inc (b)(c)
20,246
1,124,260
Surgery Partners Inc (b)(c)
44,983
600,973
26,672,570
Health Care Technology - 0.0%
Certara Inc (b)(c)
64,635
376,175
HeartFlow Inc (b)(c)
28,548
884,417
Waystar Holding Corp (b)(c)
58,392
1,162,585
2,423,177
Life Sciences Tools & Services - 0.2%
10X Genomics Inc Class A (b)
43,038
1,218,191
Adaptive Biotechnologies Corp (b)
42,372
641,935
Bio-Techne Corp (c)
38,938
2,012,316
Bruker Corp (c)
41,070
2,418,612
Fortrea Holdings Inc (b)
34,815
535,802
ICON PLC (b)
18,612
2,532,535
Illumina Inc (b)
36,220
5,902,411
Medpace Holdings Inc (b)
6,871
3,072,093
Repligen Corp (b)(c)
13,804
1,711,006
Sotera Health Co (b)
86,065
1,346,057
Tempus AI Inc Class A (b)(c)
40,682
2,053,221
23,444,179
Pharmaceuticals - 0.4%
Alumis Inc (b)(c)
33,350
720,360
Amneal Intermediate Inc Class A (b)
94,103
1,239,337
Amylyx Pharmaceuticals Inc (b)(c)
39,887
572,378
ANI Pharmaceuticals Inc (b)(c)
7,051
553,574
Arvinas Inc (b)
40,807
366,447
Atea Pharmaceuticals Inc (b)(c)
69,618
325,115
Avadel Pharmaceuticals PLC rights (b)(d)
24,906
0
Axsome Therapeutics Inc (b)
12,617
2,958,434
Belite Bio Inc ADR (b)
3,734
538,368
BioAge Labs Inc (b)(c)
20,675
357,470
Corcept Therapeutics Inc (b)
26,041
1,809,589
Crinetics Pharmaceuticals Inc (b)(c)
28,694
1,020,072
Definium Therapeutics Inc (b)
40,894
989,226
Edgewise Therapeutics Inc (b)
33,343
1,138,997
Enliven Therapeutics Inc (b)(c)
22,815
902,790
EyePoint Inc (b)
28,026
380,593
Harmony Biosciences Holdings Inc (b)
18,832
594,903
Harrow Inc (b)(c)
11,315
398,401
Indivior Pharmaceuticals Inc (c)
30,241
1,089,281
Innoviva Inc (b)(c)
31,880
682,870
Jazz Pharmaceuticals PLC (b)
13,771
3,256,704
Ligand Pharmaceuticals Inc (b)(c)
5,420
1,257,223
Ligand Pharmaceuticals Inc rights (b)
1,530
92
Ligand Pharmaceuticals Inc rights (b)
1,530
81
Ligand Pharmaceuticals Inc rights (b)
1,530
2
Ligand Pharmaceuticals Inc rights (b)
1,530
1
Liquidia Corp (b)(c)
23,239
1,437,565
Maze Therapeutics Inc (b)(c)
14,208
375,944
MBX Biosciences Inc (b)
14,062
442,531
Nektar Therapeutics (b)
6,903
447,867
Ocular Therapeutix Inc (b)
71,876
647,603
Omeros Corp (b)(c)
33,514
369,995
Rapport Therapeutics Inc (b)(c)
15,825
625,088
Relmada Therapeutics Inc (b)
29,782
214,727
Roche Holding AG rights (b)(d)
870
0
Royalty Pharma PLC Class A
95,316
5,314,820
Sanofi SA ADR
64,450
2,814,532
Sanofi SA rights (b)(d)
925
0
Septerna Inc (b)(c)
17,360
524,272
Structure Therapeutics Inc ADR (b)
20,734
815,676
Supernus Pharmaceuticals Inc (b)
19,349
893,537
Tarsus Pharmaceuticals Inc (b)
13,644
810,454
Trevi Therapeutics Inc (b)
41,948
593,145
Viatris Inc
268,445
4,364,916
WaVe Life Sciences Ltd (b)
55,660
366,242
42,211,222
TOTAL HEALTH CARE
481,775,162
Industrials - 3.1%
Aerospace & Defense - 0.5%
AeroVironment Inc (b)(c)
11,862
2,458,281
Arxis Inc Class A
14,473
650,272
Astronics Corp (b)(c)
7,760
675,120
Axon Enterprise Inc (b)
19,121
8,579,975
Firefly Aerospace Inc (b)(c)
43,369
2,016,225
FTAI Aviation Ltd
24,152
6,287,732
Intuitive Machines Inc Class A (b)(c)
37,519
1,644,458
Kratos Defense & Security Solutions Inc (b)(c)
43,958
2,819,027
Leonardo DRS Inc (c)
68,005
3,315,924
Mercury Systems Inc (b)(c)
17,416
1,945,367
Red Cat Holdings Inc (b)(c)
33,601
487,214
Rocket Lab Corp (b)
134,234
19,259,894
VSE Corp (c)
6,658
1,232,729
Woodward Inc
13,395
4,688,652
56,060,870
Air Freight & Logistics - 0.1%
CH Robinson Worldwide Inc
26,385
4,713,680
Hub Group Inc Class A (c)
21,974
912,800
5,626,480
Building Products - 0.0%
AAON Inc (c)
21,311
2,987,802
UFP Industries Inc
16,335
1,323,135
4,310,937
Commercial Services & Supplies - 0.3%
Casella Waste Systems Inc Class A (b)(c)
15,873
1,304,284
Cintas Corp
93,368
15,990,205
Copart Inc (b)
222,962
7,306,465
Fuel Tech Inc (b)
236,480
349,990
Healthcare Services Group Inc (b)(c)
32,258
664,515
Interface Inc (c)
23,319
690,242
Tetra Tech Inc
67,321
1,850,654
28,156,355
Construction & Engineering - 0.3%
Construction Partners Inc Class A (b)(c)
11,814
1,375,977
Ferrovial NV (United States)
170,904
11,623,181
IES Holdings Inc (b)(c)
5,005
3,395,142
Legence Corp Class A (c)
19,956
1,671,115
Limbach Holdings Inc (b)(c)
6,695
518,527
MYR Group Inc (b)
4,866
2,262,982
Solv Energy Inc Class A (c)
26,781
951,529
Sterling Infrastructure Inc (b)
7,494
6,451,135
WillScot Holdings Corp (c)
53,623
1,379,720
29,629,308
Electrical Equipment - 0.2%
Allient Inc (c)
9,008
713,073
American Superconductor Corp (b)(c)
18,328
933,628
Array Technologies Inc (b)(c)
50,859
461,800
Enovix Corp Class B (b)(c)
80,157
639,653
Eos Energy Enterprises Inc (b)(c)
76,447
644,448
Fluence Energy Inc Class A (b)
36,420
687,610
NANO Nuclear Energy Inc (b)
13,134
379,310
Nextpower Inc Class A (b)(c)
36,713
5,741,913
Plug Power Inc (b)(c)
383,879
1,516,322
Powell Industries Inc (c)
8,980
2,554,092
Power Solutions International Inc (b)(c)
6,928
288,759
Preformed Line Products Co (c)
2,349
868,707
Shoals Technologies Group Inc (b)
62,974
784,026
Sunrun Inc (b)
65,849
1,100,995
Terra Innovatum Global NV (c)
49,917
307,489
Vicor Corp (b)
8,284
2,773,815
X-Energy Inc (c)
62,663
1,686,261
22,081,901
Ground Transportation - 0.4%
ArcBest Corp (c)
8,382
1,145,736
Avis Budget Group Inc (b)(c)
8,842
1,554,777
CSX Corp
435,458
19,708,829
Heartland Express Inc (c)
46,744
700,693
Hertz Global Holdings Inc (b)(c)
101,982
550,703
JB Hunt Transport Services Inc
21,115
5,836,819
Landstar System Inc
9,893
2,046,862
Lyft Inc Class A (b)(c)
93,464
1,318,777
Old Dominion Freight Line Inc
49,713
11,192,882
Saia Inc (b)
6,500
3,070,405
Universal Logistics Holdings Inc (c)
20,159
320,729
Werner Enterprises Inc
23,475
974,447
48,421,659
Industrial Conglomerates - 0.3%
Honeywell International Inc
149,910
35,657,593
Icahn Enterprises LP
193,102
1,436,678
37,094,271
Machinery - 0.3%
Blue Bird Corp (b)(c)
12,355
837,298
CECO Environmental Corp (b)(c)
12,934
966,817
Franklin Electric Co Inc
13,631
1,341,018
Hillman Solutions Corp (b)
79,025
589,527
Lincoln Electric Holdings Inc
12,488
3,228,023
Microvast Holdings Inc (b)(c)
108,307
167,875
Middleby Corp/The (b)(c)
12,026
1,864,150
NN Inc (b)
114,081
338,821
Nordson Corp
12,116
3,481,290
PACCAR Inc
124,984
13,794,484
Symbotic Inc Class A (b)(c)
33,487
1,554,634
28,163,937
Passenger Airlines - 0.1%
Allegiant Travel Co (b)
7,233
662,615
American Airlines Group Inc (b)
129,113
1,890,214
JetBlue Airways Corp (b)(c)
139,970
765,636
SkyWest Inc (b)
12,555
1,075,336
United Airlines Holdings Inc (b)
74,625
8,566,950
12,960,751
Professional Services - 0.4%
Automatic Data Processing Inc
94,250
20,908,420
Concentrix Corp
21,605
611,205
ExlService Holdings Inc (b)
48,175
1,398,520
Exponent Inc
16,057
936,444
First Advantage Corp (b)(c)
63,803
1,020,848
Forrester Research Inc (b)(c)
30,470
214,813
Huron Consulting Group Inc (b)
5,823
625,332
ICF International Inc
7,961
548,035
Innodata Inc (b)(c)
7,773
816,010
Paychex Inc
83,175
8,066,312
Paylocity Holding Corp (b)
15,616
1,794,747
Science Applications International Corp
13,683
1,425,769
SS&C Technologies Holdings Inc
54,548
3,683,081
Upwork Inc (b)(c)
44,218
390,003
Verisk Analytics Inc
32,847
5,747,897
Verra Mobility Corp Class A (b)
49,835
224,756
Willdan Group Inc (b)(c)
6,179
561,300
48,973,492
Trading Companies & Distributors - 0.2%
Distribution Solutions Group Inc (b)(c)
26,380
712,260
DXP Enterprises Inc/TX (b)(c)
5,881
853,098
EquipmentShare.com Inc Class A (b)(c)
51,052
1,063,924
Fastenal Co
267,174
11,809,091
McGrath RentCorp
8,666
944,507
Rush Enterprises Inc Class A
19,062
1,321,568
Xometry Inc Class A (b)(c)
14,623
1,393,426
18,097,874
TOTAL INDUSTRIALS
339,577,835
Information Technology - 52.5%
Communications Equipment - 1.3%
Applied Optoelectronics Inc (b)(c)
17,767
2,814,470
Cisco Systems Inc
936,343
112,754,425
Digi International Inc (b)
15,258
1,019,234
Extreme Networks Inc (b)
51,352
1,361,342
F5 Inc (b)
12,804
4,909,694
Lumentum Holdings Inc (b)
16,911
14,458,229
NetScout Systems Inc (b)
27,528
1,145,715
Ondas Inc (b)(c)
109,256
1,444,364
Viasat Inc (b)(c)
34,555
2,785,824
Viavi Solutions Inc (b)
56,683
2,752,526
Vistance Networks Inc
46,863
584,850
146,030,673
Electronic Equipment, Instruments & Components - 0.5%
Advanced Energy Industries Inc
9,090
2,746,816
Aeva Technologies Inc (b)(c)
20,390
574,590
Avnet Inc
24,304
2,112,747
Bel Fuse Inc Class B (c)
3,924
1,077,216
CDW Corp/DE
30,012
3,765,005
Cognex Corp
42,390
2,791,382
ePlus Inc (c)
9,825
806,534
Flex Ltd (b)
89,974
13,566,281
Insight Enterprises Inc (b)
10,931
1,162,840
IPG Photonics Corp (b)(c)
12,801
1,465,971
Itron Inc (b)
12,347
1,018,381
Lightwave Logic Inc (b)(c)
46,406
503,969
Littelfuse Inc
6,244
2,915,136
Napco Security Technologies Inc
15,510
582,090
nLight Inc (b)
16,214
1,201,782
Novanta Inc (b)(c)
10,794
1,719,808
OSI Systems Inc (b)(c)
5,043
1,093,070
Ouster Inc Class A (b)(c)
18,526
853,122
PC Connection Inc (c)
11,113
773,354
Plexus Corp (b)
7,931
2,128,363
Sanmina Corp (b)(c)
15,067
3,913,352
TTM Technologies Inc (b)
25,127
4,365,062
Zebra Technologies Corp Class A (b)
12,123
2,953,526
54,090,397
IT Services - 0.4%
Akamai Technologies Inc (b)
35,136
5,254,237
Amdocs Ltd
27,174
1,711,147
Applied Digital Corp (b)(c)
70,292
3,323,406
Cognizant Technology Solutions Corp Class A
112,266
6,259,391
CoreWeave Inc Class A (b)
105,048
11,505,907
Fastly Inc Class A (b)
41,245
732,717
MongoDB Inc Class A (b)
19,214
6,447,258
Okta Inc Class A (b)
39,394
4,856,098
VeriSign Inc
22,044
6,290,917
46,381,078
Semiconductors & Semiconductor Equipment - 27.0%
ACM Research Inc Class A (b)
7,311
632,840
Advanced Micro Devices Inc (b)
386,817
199,636,254
Aehr Test Systems (b)
3,729
344,299
Ambarella Inc (b)
4,578
330,440
Amkor Technology Inc
58,970
4,101,953
Analog Devices Inc
115,289
47,712,353
Applied Materials Inc
188,071
84,643,234
ARM Holdings PLC ADR (b)
33,029
11,668,815
Astera Labs Inc (b)
38,607
13,236,410
Axcelis Technologies Inc (b)(c)
4,921
740,168
AXT Inc (b)(c)
13,381
1,380,384
Broadcom Inc
1,127,620
503,786,787
Cerebras Systems Inc Class A (b)
7,120
1,687,369
Cirrus Logic Inc (b)
11,458
1,947,287
Cohu Inc (b)
3,932
207,413
Credo Technology Group Holding Ltd (b)
41,205
9,725,616
Diodes Inc (b)
7,539
794,007
Enphase Energy Inc (b)
20,938
1,431,322
Entegris Inc (c)
35,883
4,980,202
First Solar Inc (b)
25,378
7,785,717
FormFactor Inc (b)
16,274
2,027,578
GlobalFoundries Inc (b)
126,969
10,153,711
Ichor Holdings Ltd (b)
2,849
203,760
Impinj Inc (b)(c)
4,095
618,345
Intel Corp (b)
1,179,525
135,267,927
KLA Corp
31,011
59,594,149
Lam Research Corp
295,925
94,157,417
Lattice Semiconductor Corp (b)
31,859
4,685,822
MACOM Technology Solutions Holdings Inc (b)
17,356
6,328,692
Marvell Technology Inc
205,959
42,221,595
MaxLinear Inc (b)
13,462
1,251,024
Microchip Technology Inc
125,298
11,859,456
Micron Technology Inc
266,227
258,506,417
MKS Inc
14,779
4,792,239
Monolithic Power Systems Inc
11,455
17,940,936
Navitas Semiconductor Corp Class A (b)(c)
28,529
758,871
NVIDIA Corp
5,783,979
1,221,229,326
ON Semiconductor Corp (b)
93,665
11,297,872
PDF Solutions Inc (b)
1,419
69,290
Photronics Inc (b)(c)
7,183
232,370
Power Integrations Inc (c)
7,849
659,316
Qorvo Inc (b)
20,898
2,164,197
QUALCOMM Inc
251,476
63,125,506
Rambus Inc (b)(c)
23,058
3,354,017
Rigetti Computing Inc Class A (b)(c)
61,351
1,566,905
Semtech Corp (b)(c)
21,469
3,274,881
Silicon Laboratories Inc (b)(c)
7,544
1,641,574
SiTime Corp (b)
5,638
4,004,108
SkyWater Technology Inc (b)
1,144
44,592
Skyworks Solutions Inc (c)
29,986
2,334,410
SolarEdge Technologies Inc (b)(c)
5,521
421,528
Synaptics Inc (b)(c)
5,295
726,898
Teradyne Inc
36,508
13,665,309
Texas Instruments Inc
214,487
65,564,386
Ultra Clean Holdings Inc (b)
6,502
556,376
Universal Display Corp (c)
7,695
708,863
Veeco Instruments Inc (b)(c)
7,552
435,297
2,944,217,830
Software - 11.8%
ACI Worldwide Inc (b)(c)
32,283
1,409,799
Adeia Inc (c)
39,558
1,056,990
Adobe Inc (b)
95,770
24,824,542
Agilysys Inc (b)(c)
11,261
974,752
Alarm.com Holdings Inc (b)
18,971
855,782
Alkami Technology Inc (b)(c)
38,500
699,545
Appfolio Inc Class A (b)(c)
7,557
1,217,962
AppLovin Corp Class A (b)
72,806
44,636,631
Atlassian Corp Class A (b)
40,262
4,332,594
Aurora Innovation Inc Class A (b)(c)
432,504
3,174,579
Autodesk Inc (b)
50,567
11,696,653
AvePoint Inc Class A (b)
84,013
916,582
Bentley Systems Inc Class B (c)
77,306
2,523,268
Bitdeer Technologies Group Class A (b)(c)
43,998
769,525
Blackbaud Inc (b)
18,099
555,457
BlackLine Inc (b)
19,783
581,619
Braze Inc Class A (b)(c)
32,858
842,151
Cadence Design Systems Inc (b)
65,687
24,628,027
Ccc Intelligent Solutions Holdings Inc Class A (b)
171,203
804,654
Cipher Digital Inc (b)(c)
96,489
2,281,965
Cleanspark Inc (b)(c)
72,330
1,322,916
Commvault Systems Inc (b)
10,870
1,290,813
Core Scientific Inc (b)(c)
74,108
1,989,800
Crowdstrike Holdings Inc Class A (b)
59,788
43,705,028
Datadog Inc Class A (b)
79,365
19,630,933
Docusign Inc (b)
48,072
2,524,741
Dropbox Inc Class A (b)
35,020
941,338
EverCommerce Inc (b)(c)
70,170
789,413
Fortinet Inc (b)
176,720
24,382,058
Freshworks Inc Class A (b)
85,159
826,894
Gen Digital Inc
134,301
3,463,623
Gitlab Inc Class A (b)
34,588
1,073,957
Hut 8 Corp (United States) (b)
28,429
3,548,792
Intapp Inc (b)(c)
28,529
658,735
InterDigital Inc (c)
6,206
1,564,471
Intuit Inc
65,531
21,725,492
JFrog Ltd (b)
29,593
2,352,052
Keel Infrastructure Corp (c)
161,084
914,957
Life360 Inc (b)(c)
20,293
862,250
Manhattan Associates Inc (b)
14,049
2,108,052
MARA Holdings Inc (b)(c)
98,363
1,414,460
Microsoft Corp
1,767,400
795,754,176
Monday.com Ltd (b)(c)
11,964
1,000,430
nCino Inc (b)
40,894
657,575
NextNav Inc Class A (b)(c)
49,962
1,030,216
Nutanix Inc Class A (b)
62,614
3,260,311
Palantir Technologies Inc Class A (b)
543,154
85,025,327
Palo Alto Networks Inc (b)
192,613
54,257,156
Pegasystems Inc (c)
43,026
1,537,319
Progress Software Corp (b)
17,675
580,269
PTC Inc (b)
28,006
3,885,272
Qualys Inc (b)
10,370
1,133,337
Rezolve AI PLC (b)(c)
107,707
320,966
Riot Platforms Inc (b)
96,240
2,609,066
Roper Technologies Inc
24,290
7,907,124
SailPoint Inc (b)(c)
149,765
2,820,075
ServiceTitan Inc Class A (b)
21,134
1,529,256
SoundHound AI Inc Class A (b)(c)
92,767
834,903
SPS Commerce Inc (b)
12,706
721,066
Strategy Inc Class A (b)(c)
75,726
12,047,249
Synopsys Inc (b)
45,665
21,719,187
Tenable Holdings Inc (b)
41,729
1,178,010
Terawulf Inc (b)(c)
102,087
2,609,344
Trimble Inc (b)
53,558
3,021,207
Varonis Systems Inc (b)
35,030
1,196,275
Workday Inc Class A (b)
52,157
7,624,832
Zoom Communications Inc Class A (b)
63,335
6,434,203
Zscaler Inc (b)
39,881
5,572,572
1,292,140,575
Technology Hardware, Storage & Peripherals - 11.5%
Apple Inc
3,494,565
1,090,513,954
NetApp Inc
45,480
7,926,709
Quantum Computing Inc (b)(c)
78,272
936,132
Sandisk Corp/DE (b)
35,046
59,402,269
Seagate Technology Holdings PLC
51,697
45,483,021
Super Micro Computer Inc (b)
140,796
6,489,288
Western Digital Corp
80,284
42,647,664
1,253,399,037
TOTAL INFORMATION TECHNOLOGY
5,736,259,590
Materials - 0.8%
Chemicals - 0.6%
Balchem Corp
9,424
1,477,024
Hawkins Inc (c)
7,171
1,109,856
Innospec Inc
9,699
804,434
Linde PLC
109,656
54,574,695
PureCycle Technologies Inc (b)(c)
75,382
933,983
Solstice Advanced Materials Inc
39,192
3,301,142
62,201,134
Construction Materials - 0.0%
United States Lime & Minerals Inc
9,418
1,073,558
Containers & Packaging - 0.0%
TriMas Corp
18,285
748,405
Metals & Mining - 0.2%
Aura Minerals Inc
22,316
1,724,357
Century Aluminum Co (b)
24,137
1,592,318
Evolution Metals & Technologies Corp (b)(c)
146,185
986,749
Hycroft Mining Holding Corp (b)(c)
23,614
780,443
Kaiser Aluminum Corp
6,181
1,125,189
NioCorp Developments Ltd (b)(c)
69,608
401,638
Perpetua Resources Corp (United States) (b)(c)
32,394
876,906
Ramaco Resources Inc Class A (b)(c)
21,663
338,159
Royal Gold Inc
20,422
4,584,331
Steel Dynamics Inc
34,754
9,041,253
USA Rare Earth Inc Class A (b)(c)
55,201
1,546,180
22,997,523
TOTAL MATERIALS
87,020,620
Real Estate - 0.5%
Health Care REITs - 0.0%
Diversified Healthcare Trust
100,576
836,791
Sabra Health Care REIT Inc
74,958
1,490,915
2,327,706
Hotel & Resort REITs - 0.0%
DiamondRock Hospitality Co
81,856
899,597
Host Hotels & Resorts Inc
147,464
3,388,723
4,288,320
Industrial REITs - 0.0%
Lineage Inc
62,716
2,785,218
Real Estate Management & Development - 0.1%
Comstock Holding Cos Inc Class A (b)
39,752
605,820
CoStar Group Inc (b)
99,296
3,197,331
eXp World Holdings Inc (c)
92,174
453,496
Newmark Group Inc Class A
56,883
794,656
Opendoor Technologies Inc Class A (b)(c)
233,714
1,177,919
Opendoor Technologies Inc warrants 11/20/2026 (b)
6,190
4,147
Opendoor Technologies Inc warrants 11/20/2026 (b)
6,190
1,919
Opendoor Technologies Inc warrants 11/20/2026 (b)
6,190
1,610
Zillow Group Inc Class A (b)(c)
11,444
404,660
Zillow Group Inc Class C (b)
44,350
1,552,250
8,193,808
Retail REITs - 0.0%
Phillips Edison & Co Inc
38,009
1,526,061
Regency Centers Corp
39,453
3,051,690
4,577,751
Specialized REITs - 0.4%
Equinix Inc
23,078
24,648,228
Fermi Inc (c)
156,488
1,092,286
Gaming and Leisure Properties Inc
60,653
2,848,871
Lamar Advertising Co Class A
19,160
2,921,134
SBA Communications Corp Class A
23,752
4,825,456
36,335,975
TOTAL REAL ESTATE
58,508,778
Utilities - 0.8%
Electric Utilities - 0.7%
Alliant Energy Corp (c)
56,835
4,069,954
American Electric Power Co Inc
126,350
16,004,755
Constellation Energy Corp
86,077
24,768,658
Evergy Inc
50,986
4,182,891
Exelon Corp
236,960
10,814,854
MGE Energy Inc (c)
12,791
965,721
Otter Tail Corp (c)
13,492
1,169,217
Xcel Energy Inc
144,562
11,492,679
73,468,729
Independent Power and Renewable Electricity Producers - 0.1%
Fervo Energy Co (b)
65,433
2,398,774
Hallador Energy Co (b)(c)
27,004
520,097
Montauk Renewables Inc (b)(c)
127,664
222,135
Talen Energy Corp (b)
10,685
4,132,958
7,273,964
Multi-Utilities - 0.0%
Northwestern Energy Group Inc
19,122
1,350,204
Water Utilities - 0.0%
H2O America
14,078
814,131
Middlesex Water Co (c)
10,503
551,722
1,365,853
TOTAL UTILITIES
83,458,750
TOTAL UNITED STATES
10,542,827,006
URUGUAY - 0.0%
Financials - 0.0%
Financial Services - 0.0%
Dlocal Ltd/Uruguay Class A (c)
56,351
668,323
VIETNAM - 0.0%
Consumer Discretionary - 0.0%
Automobiles - 0.0%
Vinfast Auto Ltd (b)(c)
645,562
2,253,011
TOTAL COMMON STOCKS
(Cost $4,239,507,180)
10,863,453,371
U.S. Treasury Obligations - 0.0%
Yield (%) (e)
Principal
Amount (a)
Value ($)
US Treasury Bills 0% 8/13/2026 (f)
(Cost $2,163,047)
3.64
2,179,000
2,163,137
Money Market Funds - 3.0%
Yield (%)
Shares
Value ($)
Fidelity Cash Central Fund (g)
3.67
50,996,412
51,006,611
Fidelity Securities Lending Cash Central Fund (g)(h)
3.67
279,478,083
279,506,031
TOTAL MONEY MARKET FUNDS
(Cost $330,510,440)
330,512,642
TOTAL INVESTMENT IN SECURITIES - 102.5%
(Cost $4,572,180,667)
11,196,129,150
NET OTHER ASSETS (LIABILITIES) - (2.5)%
(273,626,236)
NET ASSETS - 100.0%
10,922,502,914
Futures Contracts
Number
of contracts
Expiration
Date
Notional
Amount ($)
Value and Unrealized
Appreciation/
(Depreciation) ($)
LONG
CME E-Mini Nasdaq 100 Index Contracts (United States)
97
6/2026
58,986,185
8,710,085

Legend
(a)
Amount is stated in United States dollars unless otherwise noted.
(b)
Non-income producing.
(c)
Security or a portion of the security is on loan at period end.
(d)
Level 3 security.
(e)
Yield represents either the annualized yield at the date of purchase, or the stated coupon rate, or, for floating and adjustable rate securities, the rate at period end.
(f)
Security or a portion of the security was pledged to cover margin requirements for futures contracts. At period end, the value of securities pledged amounted to $2,163,137.
(g)
Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.
(h)
Investment made with cash collateral received from securities on loan.
Affiliated Central Funds
Fiscal year to date information regarding the Fund's investments in Fidelity Central Funds, including the ownership percentage, is presented below.
Affiliate
Value,
beginning
of period ($)
Purchases ($)
Sales
Proceeds ($)
Dividend
Income ($)
Realized
Gain (loss) ($)
Change in
Unrealized
appreciation
(depreciation) ($)
Value,
end
of period ($)
Shares,
end
of period
% ownership,
end
of period
Fidelity Cash Central Fund
21,149,583
145,445,465
115,588,729
584,719
293
(1)
51,006,611
50,996,412
0.1%
Fidelity Securities Lending Cash Central Fund
253,753,198
1,575,914,471
1,550,160,543
4,963,206
(1,095)
-
279,506,031
279,478,083
0.8%
Total
274,902,781
1,721,359,936
1,665,749,272
5,547,925
(802)
(1)
330,512,642
Amounts in the dividend income column in the above table include any capital gain distributions from underlying funds, which are presented in the corresponding line item in the Statement of Operations, if applicable.
Amounts in the dividend income column for Fidelity Securities Lending Cash Central Fund represents the income earned on investing cash collateral, less rebates paid to borrowers and any lending agent fees associated with the loan, plus any premium income received for lending certain types of securities.
Amounts included in the purchases and sales proceeds columns may include in-kind transactions, if applicable.
Investment Valuation
The following is a summary of the inputs used, as of May 31, 2026, involving the Fund's assets and liabilities carried at fair value. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. For more information on valuation inputs, and their aggregation into the levels used below, please refer to the Investment Valuation section in the accompanying Notes to Financial Statements.
Valuation Inputs at Reporting Date:
Description
Total ($)
Level 1 ($)
Level 2 ($)
Level 3 ($)
Investments in Securities:
Common Stocks
Communication Services
1,622,475,216
1,621,805,860
-
669,356
Consumer Discretionary
1,380,807,319
1,380,807,319
-
-
Consumer Staples
482,268,417
482,268,417
-
-
Energy
54,793,210
54,793,210
-
-
Financials
323,683,921
323,683,921
-
-
Health Care
510,349,227
510,331,670
-
17,557
Industrials
368,354,921
368,354,921
-
-
Information Technology
5,877,350,155
5,877,350,155
-
-
Materials
94,432,449
94,432,449
-
-
Real Estate
61,654,775
61,654,775
-
-
Utilities
87,283,761
87,283,761
-
-
U.S. Treasury Obligations
2,163,137
-
2,163,137
-
Money Market Funds
330,512,642
330,512,642
-
-
Total Investments in Securities:
11,196,129,150
11,193,279,100
2,163,137
686,913
Derivative Instruments:
Assets
Futures Contracts
8,710,085
8,710,085
-
-
Total Assets
8,710,085
8,710,085
-
-
Total Derivative Instruments:
8,710,085
8,710,085
-
-
Value of Derivative Instruments
The following table is a summary of the Fund's value of derivative instruments by primary risk exposure as of May 31, 2026. For additional information on derivative instruments, please refer to the Derivative Instruments section in the accompanying Notes to Financial Statements.
Primary Risk Exposure / Derivative Type
Value
Asset ($)
Liability ($)
Equity Risk
Futures Contracts (a)
8,710,085
-
Total Equity Risk
8,710,085
-
Total Value of Derivatives
8,710,085
-
(a)Reflects gross cumulative appreciation (depreciation) on futures contracts as presented in the Schedule of Investments. In the Statement of Assets and Liabilities, the period end daily variation margin is included in receivable or payable for daily variation margin on futures contracts, and the net cumulative appreciation (depreciation) is included in Total accumulated earnings (loss).
Financial Statements (Unaudited)
Statement of Assets and Liabilities
As of May 31, 2026 (Unaudited)
Assets
Investment in securities, at value (including securities loaned of $386,613,181) - See accompanying schedule:
Unaffiliated issuers (cost $4,241,670,227)
$
10,865,616,508
Fidelity Central Funds (cost $330,510,440)
330,512,642
Total Investment in Securities (cost $4,572,180,667)
$
11,196,129,150
Segregated cash with brokers for derivative instruments
1,336,427
Cash
5
Foreign currency held at value (cost $157,598)
160,353
Receivable for investments sold
745,407
Dividends receivable
4,135,839
Distributions receivable from Fidelity Central Funds
1,174,282
Receivable for variation margin on futures contracts
188,761
Other receivables
194
Total assets
11,203,870,418
Liabilities
Accrued management fee
$
1,843,254
Other payables and accrued expenses
67
Collateral on securities loaned
279,524,183
Total liabilities
281,367,504
Net Assets
$
10,922,502,914
Net Assets consist of:
Paid in capital
$
4,287,765,328
Total accumulated earnings (loss)
6,634,737,586
Net Assets
$
10,922,502,914
Net Asset Value, offering price and redemption price per share ($10,922,502,914 ÷ 102,850,000 shares)
$
106.20
Statement of Operations
Six months ended May 31, 2026 (Unaudited)
Investment Income
Dividends
$
29,202,676
Interest
41,793
Income from Fidelity Central Funds (including $4,963,206 from security lending)
5,547,925
Security lending
25,182
Total income
34,817,576
Expenses
Management fee
$
9,931,874
Independent trustees' fees and expenses
12,240
Total expenses before reductions
9,944,114
Expense reductions
(7,725)
Total expenses after reductions
9,936,389
Net Investment income (loss)
24,881,187
Realized and Unrealized Gain (Loss)
Net realized gain (loss) on:
Investment Securities:
Unaffiliated issuers
2,525,878
Redemptions in-kind
265,250,854
Fidelity Central Funds
(802)
Foreign currency transactions
2,146
Futures contracts
(340,450)
Total net realized gain (loss)
267,437,626
Change in net unrealized appreciation (depreciation) on:
Investment Securities:
Unaffiliated issuers
1,178,664,808
Fidelity Central Funds
(1)
Assets and liabilities in foreign currencies
40,540
Futures contracts
7,700,398
Total change in net unrealized appreciation (depreciation)
1,186,405,745
Net gain (loss)
1,453,843,371
Net increase (decrease) in net assets resulting from operations
$
1,478,724,558
Statement of Changes in Net Assets
Six months ended
May 31, 2026
(Unaudited)
Year ended
November 30, 2025
Increase (Decrease) in Net Assets
Operations
Net investment income (loss)
$
24,881,187
$
46,667,928
Net realized gain (loss)
267,437,626
73,518,332
Change in net unrealized appreciation (depreciation)
1,186,405,745
1,569,509,931
Net increase (decrease) in net assets resulting from operations
1,478,724,558
1,689,696,191
Distributions to shareholders
(26,157,150)
(51,225,950)
Share transactions
Proceeds from sales of shares
466,631,477
496,860,596
Cost of shares redeemed
(326,917,689)
(179,797,263)
Net increase (decrease) in net assets resulting from share transactions
139,713,788
317,063,333
Total increase (decrease) in net assets
1,592,281,196
1,955,533,574
Net Assets
Beginning of period
9,330,221,718
7,374,688,144
End of period
$
10,922,502,914
$
9,330,221,718
Other Information
Shares
Sold
4,950,000
6,500,000
Redeemed
(3,550,000)
(2,400,000)
Net increase (decrease)
1,400,000
4,100,000
Financial Highlights
Fidelity® Nasdaq Composite Index® ETF
Six months ended
May 31, 2026
(Unaudited)
Years ended November 30, 2025
2024
2023
2022
2021 A
Selected Per-Share Data
Net asset value, beginning of period
$
91.97
$
75.75
$
56.13
$
45.09
$
60.49
$
47.46
Income from Investment Operations
Net investment income (loss) B,C
.24
.47
.45
.40
.40
.34
Net realized and unrealized gain (loss)
14.25
16.26
19.63
11.07
(15.43)
13.01
Total from investment operations
14.49
16.73
20.08
11.47
(15.03)
13.35
Distributions from net investment income
(.26)
(.51)
(.46)
(.43)
(.37)
(.32)
Total distributions
(.26)
(.51)
(.46)
(.43)
(.37)
(.32)
Net asset value, end of period
$
106.20
$
91.97
$
75.75
$
56.13
$
45.09
$
60.49
Total Return D,E,F
15.81
%
22.20%
35.93%
25.60%
(24.90)%
28.23%
Ratios to Average Net Assets C,G,H
Expenses before reductions
.21% I
.21%
.21%
.21%
.21%
.21%
Expenses net of fee waivers, if any
.21
% I
.21%
.21%
.21%
.21%
.21%
Expenses net of all reductions, if any
.21% I
.21%
.21%
.21%
.21%
.21%
Net investment income (loss)
.53% I
.59%
.67%
.81%
.81%
.62%
Supplemental Data
Net assets, end of period (000 omitted)
$
10,922,503
$
9,330,222
$
7,374,688
$
5,214,013
$
3,999,432
$
4,784,708
Portfolio turnover rate J
6
% I
5%
5%
4%
8%
11%
APer share amounts have been adjusted to reflect the impact of the 10 for 1 share split that occurred on April 8, 2021.
BCalculated based on average shares outstanding during the period.
CNet investment income (loss) is affected by the timing of the declaration of dividends by any underlying mutual funds or exchange-traded funds (ETFs). Net investment income (loss) of any mutual funds or ETFs is not included in the Fund's net investment income (loss) ratio.
DTotal returns for periods of less than one year are not annualized.
ETotal returns would have been lower if certain expenses had not been reduced during the applicable periods shown.
FBased on net asset value.
GFees and expenses of any underlying mutual funds or exchange-traded funds (ETFs) are not included in the Fund's expense ratio. The Fund indirectly bears its proportionate share of these expenses. For additional expense information related to investments in Fidelity Central Funds, please refer to the "Investments in Fidelity Central Funds" note found in the Notes to Financial Statements section of the most recent Annual or Semi-Annual report.
HExpense ratios reflect operating expenses of the class. Expenses before reductions do not reflect amounts reimbursed, waived, or reduced through arrangements with the investment adviser, brokerage services, or other offset arrangements, if applicable, and do not represent the amount paid by the class during periods when reimbursements, waivers or reductions occur.
IAnnualized.
JAmount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs), derivatives or securities that mature within one year from acquisition.
Notes to Financial Statements
(Unaudited)
For the period ended May 31, 2026
1. Organization.
Fidelity Nasdaq Composite Index ETF (the Fund) is an exchange-traded fund of Fidelity Commonwealth Trust (the Trust) and is authorized to issue an unlimited number of shares. The Trust is registered under the Investment Company Act of 1940, as amended (the 1940 Act), as an open-end management investment company organized as a Massachusetts business trust. The Fund may operate as a non-diversified fund, as defined under the 1940 Act, to the approximate extent the Index is non-diversified.
2. Investments in Fidelity Central Funds.
Funds may invest in Fidelity Central Funds, which are open-end investment companies generally available only to other investment companies and accounts managed by the investment adviser and its affiliates. The Schedule of Investments lists any Fidelity Central Funds held as an investment as of period end, but does not include the underlying holdings of each Fidelity Central Fund. An investing fund indirectly bears its proportionate share of the expenses of the underlying Fidelity Central Funds.
Based on its investment objective, each Fidelity Central Fund may invest or participate in various investment vehicles or strategies that are similar to those of the investing fund. These strategies are consistent with the investment objectives of the investing fund and may involve certain economic risks which may cause a decline in value of each of the Fidelity Central Funds and thus a decline in the value of the investing fund.
Fidelity Central Fund
Investment Manager
Investment Objective
Investment Practices
Expense RatioA
Fidelity Money Market Central Funds
Fidelity Management & Research Company LLC (FMR)
Each fund seeks to obtain a high level of current income consistent with the preservation of capital and liquidity.
Short-term Investments
Less than .005%
A Expenses expressed as a percentage of average net assets and are as of each underlying Central Fund's most recent annual or semi-annual shareholder report.
A complete unaudited list of holdings for each Fidelity Central Fund is available upon request or at the Securities and Exchange Commission website at www.sec.gov. In addition, the financial statements of the Fidelity Central Funds which contain the significant accounting policies (including investment valuation policies) of those funds, and are not covered by the Report of Independent Registered Public Accounting Firm, are available on the Securities and Exchange Commission website or upon request.
3. Significant Accounting Policies.
The Fund is an investment company and applies the accounting and reporting guidance of the Financial Accounting Standards Board (FASB) Accounting Standards Codification Topic 946 Financial Services - Investment Companies. The financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (GAAP), which require management to make certain estimates and assumptions at the date of the financial statements. Actual results could differ from those estimates. The Fund operates as a single operating segment. The Fund's portfolio management team, part of the investment adviser, serves as the chief operating decision maker (CODM) and directs the Fund's investments in accordance with its investment objective and policies, with support from others responsible for oversight functions. The information reviewed by the CODM is consistent with the Fund's financial statements and financial highlights. Subsequent events, if any, through the date that the financial statements were issued have been evaluated in the preparation of the financial statements. The Fund's Schedule of Investments lists any underlying mutual funds or exchange-traded funds but does not include the underlying holdings of these funds. The following summarizes the significant accounting policies of the Fund:
Investment Valuation. Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. The Board of Trustees (the Board) has designated the Fund's investment adviser as the valuation designee responsible for the fair valuation function and performing fair value determinations as needed. The investment adviser has established a Fair Value Committee (the Committee) to carry out the day-to-day fair valuation responsibilities and has adopted policies and procedures to govern the fair valuation process and the activities of the Committee. In accordance with these fair valuation policies and procedures, which have been approved by the Board, the Fund attempts to obtain prices from one or more third party pricing services or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with the policies and procedures. Factors used in determining fair value vary by investment type and may include market or investment specific events, transaction data, estimated cash flows, and market observations of comparable investments. The frequency that the fair valuation procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee manages the Fund's fair valuation practices and maintains the fair valuation policies and procedures. The Fund's investment adviser reports to the Board information regarding the fair valuation process and related material matters.
The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels as shown below:
Level 1 - unadjusted quoted prices in active markets for identical investments
Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, etc.)
Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available)
Valuation techniques used to value the Fund's investments by major category are as follows:
Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing service on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy.
Debt securities, including restricted securities, are valued based on evaluated prices received from third party pricing services or from brokers who make markets in such securities. U.S. government and government agency obligations are valued by pricing services who utilize matrix pricing which considers prepayment speed assumptions, attributes of the collateral, yield or price of bonds of comparable quality, coupon, maturity and type or by broker-supplied prices. When independent prices are unavailable or unreliable, debt securities may be valued utilizing pricing methodologies which consider similar factors that would be used by third party pricing services. Debt securities are generally categorized as Level 2 in the hierarchy but may be Level 3 depending on the circumstances.
Futures contracts are valued at the settlement price established each day by the board of trade or exchange on which they are traded and are categorized as Level 1 in the hierarchy. Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value (NAV) each business day and are categorized as Level 1 in the hierarchy.
Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. The aggregate value of investments by input level as of May 31, 2026 is included at the end of the Fund's Schedule of Investments.
Foreign Currency. Certain Funds may use foreign currency contracts to facilitate transactions in foreign-denominated securities. Gains and losses from these transactions may arise from changes in the value of the foreign currency or if the counterparties do not perform under the contracts' terms.
Foreign-denominated assets, including investment securities, and liabilities are translated into U.S. dollars at the exchange rates at period end. Purchases and sales of investment securities, income and dividends received, and expenses denominated in foreign currencies are translated into U.S. dollars at the exchange rate in effect on the transaction date.
The effects of exchange rate fluctuations on investments are included with the net realized and unrealized gain (loss) on investment securities. Other foreign currency transactions resulting in realized and unrealized gain (loss) are disclosed separately.
Investment Transactions and Income. For financial reporting purposes, the Fund's investment holdings and NAV include trades executed through the end of the last business day of the period. The NAV per share for processing shareholder transactions is calculated as of the close of business of the New York Stock Exchange (NYSE), normally 4:00 p.m. Eastern time and includes trades executed through the end of the prior business day. Gains and losses on securities sold are determined on the basis of identified cost and include proceeds received from litigation. Commissions paid to certain brokers with whom the investment adviser, or its affiliates, places trades on behalf of a fund include an amount in addition to trade execution, which may be rebated back to a fund. Any such rebates are included in net realized gain (loss) on investments in the Statement of Operations. Dividend income is recorded on the ex-dividend date, except for certain dividends from foreign securities where the ex-dividend date may have passed, which are recorded as soon as the Fund is informed of the ex-dividend date. Non-cash dividends, if any, are recorded at the fair market value of the securities received. Income and capital gain distributions from Fidelity Central Funds, if any, are recorded on the ex-dividend date. Certain distributions received by the Fund represent a return of capital or capital gain. The Fund determines the components of these distributions subsequent to the ex-dividend date, based upon receipt of tax filings or other correspondence relating to the underlying investment. These distributions are recorded as a reduction of cost of investments and/or as a realized gain. Interest income is accrued as earned and includes coupon interest and amortization of premium and accretion of discount on debt securities as applicable. Investment income is recorded net of foreign taxes withheld where recovery of such taxes is uncertain. Funds may file withholding tax reclaims in certain jurisdictions to recover a portion of amounts previously withheld. Any withholding tax reclaims income is included in the Statement of Operations in dividends. Any receivables for withholding tax reclaims are included in the Statement of Assets and Liabilities in dividends receivable.
Expenses. Expenses directly attributable to a fund are charged to that fund. Expenses attributable to more than one fund are allocated among the respective funds on the basis of relative net assets or other appropriate methods. Expenses included in the accompanying financial statements reflect the expenses of that fund and do not include any expenses associated with any underlying mutual funds or exchange-traded funds. Although not included in a fund's expenses, a fund indirectly bears its proportionate share of these expenses through the net asset value of each underlying mutual fund or exchange-traded fund. Expense estimates are accrued in the period to which they relate and adjustments are made when actual amounts are known.
Income Tax Information and Distributions to Shareholders. Each year, the Fund intends to qualify as a regulated investment company under Subchapter M of the Internal Revenue Code, including distributing substantially all of its taxable income and realized gains. As a result, no provision for U.S. Federal income taxes is required. The Fund files a U.S. federal tax return, in addition to state and local tax returns as required. The Fund's federal income tax returns are subject to examination by the Internal Revenue Service (IRS) for a period of three fiscal years after they are filed. State and local tax returns may be subject to examination for an additional fiscal year depending on the jurisdiction. Realized gain or loss resulting from in-kind redemptions is not taxable to the Fund and is not distributed to shareholders of the Fund. Foreign taxes are provided for based on the Fund's understanding of the tax rules and rates that exist in the foreign markets in which it invests.
Distributions are recorded on the ex-dividend date. Income and capital gain distributions are determined in accordance with income tax regulations, which may differ from GAAP.
Capital accounts within the financial statements are adjusted for permanent book-tax differences. These adjustments have no impact on net assets or the results of operations. Capital accounts are not adjusted for temporary book-tax differences which will reverse in a subsequent period.
Book-tax differences are primarily due to futures contracts, foreign currency transactions, passive foreign investment companies (PFIC), redemptions in-kind, partnerships, capital loss carryforwards and losses deferred due to wash sales.
As of period end, the cost and unrealized appreciation (depreciation) in securities, and derivatives if applicable, for federal income tax purposes were as follows:
Gross unrealized appreciation
$6,839,281,689
Gross unrealized depreciation
(210,656,849)
Net unrealized appreciation (depreciation)
$6,628,624,840
Tax cost
$4,576,214,395
Capital loss carryforwards are only available to offset future capital gains of the Fund to the extent provided by regulations and may be limited. The capital loss carryforward information presented below, including any applicable limitation, is estimated as of prior fiscal period end and is subject to adjustment.
Short-term
$(106,503,795)
Long-term
(153,325,191)
Total capital loss carryforward
$(259,828,986)
4. Derivative Instruments.
Risk Exposures and the Use of Derivative Instruments. The Fund's investment objectives allow for various types of derivative instruments, including futures contracts. Derivatives are investments whose value is primarily derived from underlying assets, indices or reference rates and may be transacted on an exchange or over-the-counter (OTC). Derivatives may involve a future commitment to buy or sell a specified asset based on specified terms, to exchange future cash flows at periodic intervals based on a notional principal amount, or for one party to make one or more payments upon the occurrence of specified events in exchange for periodic payments from the other party.
Derivatives were used to increase returns and to manage exposure to certain risks as defined below. The success of any strategy involving derivatives depends on analysis of numerous economic factors, and if the strategies for investment do not work as intended, the objectives may not be achieved.
Derivatives were used to increase or decrease exposure to the following risk(s):
Equity Risk
Equity risk relates to the fluctuations in the value of financial instruments as a result of changes in market prices (other than those arising from interest rate risk or foreign exchange risk), whether caused by factors specific to an individual investment, its issuer, or all factors affecting all instruments traded in a market or market segment.
Funds are also exposed to additional risks from investing in derivatives, such as liquidity risk and counterparty credit risk. Liquidity risk is the risk that a fund will be unable to close out the derivative in the open market in a timely manner. Counterparty credit risk is the risk that the counterparty will not be able to fulfill its obligation to a fund. Counterparty credit risk related to exchange-traded contracts may be mitigated by the protection provided by the exchange on which they trade.
Investing in derivatives may involve greater risks than investing in the underlying assets directly and, to varying degrees, may involve risk of loss in excess of any initial investment and collateral received and amounts recognized in the Statement of Assets and Liabilities. In addition, there may be the risk that the change in value of the derivative contract does not correspond to the change in value of the underlying instrument.
Futures Contracts. A futures contract is an agreement between two parties to buy or sell a specified underlying instrument for a fixed price at a specified future date. Futures contracts were used to manage exposure to the stock market.
Upon entering into a futures contract, a fund is required to deposit either cash or securities (initial margin) with a clearing broker in an amount equal to a certain percentage of the face value of the contract. Futures contracts are marked-to-market daily. Subsequent payments from or to a fund are made or as needed depending on the fluctuations in the value of the futures contracts and are recorded as unrealized appreciation or (depreciation). This receivable and/or payable, if any, is included in variation margin on futures contracts in the Statement of Assets and Liabilities. Realized gain or (loss) is recorded upon the expiration or closing of a futures contract. The net realized gain (loss) and change in net unrealized appreciation (depreciation) on futures contracts during the period is presented in the Statement of Operations.
Any open futures contracts at period end are presented in the Schedule of Investments under the caption "Futures Contracts". The notional amount at value reflects each contract's exposure to the underlying instrument or index at period end, and is representative of volume of activity during the period.
Any securities deposited to meet initial margin requirements are identified in the Schedule of Investments. Any cash deposited to meet initial margin requirements is presented as segregated cash with brokers for derivative instruments in the Statement of Assets and Liabilities.
5. Purchases and Sales of Investments.
Purchases and sales of securities, other than short-term securities, U.S. government securities and in-kind transactions, as applicable, are noted in the table below.
Purchases ($)
Sales ($)
Fidelity Nasdaq Composite Index ETF
502,291,365
302,487,092
Securities received and delivered in-kind through subscriptions and redemptions are noted in the table below.
In-Kind Subscriptions ($)
In-Kind Redemptions ($)
Fidelity Nasdaq Composite Index ETF
256,018,549
324,944,343
6. Fees and Other Transactions with Affiliates.
Management Fee. Fidelity Management & Research Company LLC (the investment adviser) and its affiliates provide the Fund with investment management related services for which the Fund pays a monthly management fee. The Fund pays an all-inclusive management fee based on annual rate of .21% of the Fund's average net assets; and the investment adviser pays all ordinary operating expenses of the Fund, except fees and expenses of the independent Trustees and certain miscellaneous expenses such as proxy and shareholder meeting expenses.
Sub-Adviser. Geode Capital Management, LLC (Geode), serves as sub-adviser for the Fund. Geode provides discretionary investment advisory services to the Fund and is paid by the investment adviser for providing these services.
Interfund Trades. Funds may purchase from or sell securities to other Fidelity Funds under procedures adopted by the Board of Trustees. The procedures have been designed to ensure these interfund trades are executed in accordance with Rule 17a-7 of the 1940 Act. Any interfund trades are included within the respective purchases and sales amounts shown in the Purchases and Sales of Investments note. Interfund trades during the period are noted in the table below.
Purchases ($)
Sales ($)
Realized Gain (Loss) ($)
Fidelity Nasdaq Composite Index ETF
3,732,255
18,389,220
(1,644,559)
7. Security Lending.
Funds lend portfolio securities from time to time in order to earn additional income. Lending agents are used, including National Financial Services (NFS), an affiliate of the investment adviser. Pursuant to a securities lending agreement, NFS will receive a fee, which is capped at 9.9% of a fund's daily lending revenue, for its services as lending agent. A fund may lend securities to certain qualified borrowers, including NFS. On the settlement date of the loan, the borrowers provide collateral (in the form of U.S. Treasury obligations, letters of credit and/or cash) against the loaned securities and maintains collateral in an amount not less than 100% of the fair value of the loaned securities during the period of the loan. The fair value of the loaned securities is determined at the close of business of a fund and any additional required collateral is delivered to a fund on the next business day. A fund or borrower may terminate the loan at any time, and if the borrower defaults on its obligation to return the securities loaned because of insolvency or other reasons, a fund may apply collateral received from the borrower against the obligation. A fund may experience delays and costs in recovering the securities loaned or gaining access to non-cash collateral. Any cash collateral received is invested in the Fidelity Securities Lending Cash Central Fund. Any loaned securities are identified as such in the Schedule of Investments, and the value of loaned securities and cash collateral at period end, as applicable, are presented in the Statement of Assets and Liabilities. For cash collateral, securities lending income represents the income earned on investing cash collateral less rebates paid to borrowers, plus any premium income received and is presented in the Statement of Operations as a component of income from Fidelity Central Funds. For non-cash collateral, securities lending income represents fees received from borrowers as compensation for the securities loaned and is presented in the Statement of Operations in security lending. Securities lending income is reduced by any lending agent fees associated with the loan. Affiliated security lending activity, if any, was as follows:
Total Security Lending Fees Paid to NFS ($)
Security Lending Income From Securities Loaned to NFS ($)
Value of Securities Loaned to NFS at Period End ($)
Fidelity Nasdaq Composite Index ETF
541,955
28,906
105,087
At period end, the value of any non-cash collateral is presented below. Non-cash collateral is held by a third-party bank for the benefit of a fund and the borrower. A fund is not permitted to sell or re-pledge non-cash collateral except in the event of borrower default, and therefore it is not included in the Schedule of Investments or Statement of Assets and Liabilities.
Amount ($)
Fidelity Nasdaq Composite Index ETF
118,874,057
8. Expense Reductions.
Through arrangements with the Fund's custodian, credits realized as a result of certain uninvested cash balances were used to reduce the Fund's expenses by $7,725.
9. Share Transactions.
Funds issue and redeem shares at NAV only with certain authorized participants in large increments known as Creation Units. Purchases of Creation Units are made by tendering a basket of designated securities to a fund and redemption proceeds are paid with a basket of securities from a fund's portfolio with a balancing cash component to equate the market value of the basket of securities delivered or redeemed to the NAV per Creation Unit on the transaction date. Cash may be substituted equivalent to the value of certain securities generally when they are not available in sufficient quantity for delivery. A fund's shares are available in smaller increments to investors in the secondary market at market prices and may be subject to commissions. Authorized participants pay a transaction fee to the shareholder servicing agent when purchasing and redeeming Creation Units of a fund. The transaction fee is used to offset the costs associated with the issuance and redemption of Creation Units.
10. Other.
A fund's organizational documents provide former and current trustees and officers with a limited indemnification against liabilities arising in connection with the performance of their duties to the fund. In the normal course of business, a fund may also enter into contracts that provide general indemnifications. A fund's maximum exposure under these arrangements is unknown as this would be dependent on future claims that may be made against a fund. The risk of material loss from such claims is considered remote.
11. Risk and Uncertainties.
Many factors affect a fund's performance. Developments that disrupt global economies and financial markets, such as public health emergencies, military conflicts, terrorism, government restrictions, political changes, and environmental disasters, may significantly affect a fund's investment performance. The effects of these developments to a fund will be impacted by the types of securities in which a fund invests, the financial condition, industry, economic sector, and geographic location of an issuer, and a fund's level of investment in the securities of that issuer. Significant concentrations in security types, issuers, industries, sectors, and geographic locations may magnify the factors that affect a fund's performance.
Item 8: Changes in and Disagreements with Accountants for Open-End Management Investment Companies
(Unaudited)
Note: This is not applicable for any fund included in this document.
Item 9: Proxy Disclosures for Open-End Management Investment Companies
(Unaudited)
Note: This is not applicable for any fund included in this document.
Item 10: Remuneration Paid to Directors, Officers, and others of Open-End Management Investment Companies
(Unaudited)
Note: This information is disclosed as part of the financial statements for each Fund as part of Item 7: Financial Statements and Financial Highlights for Open-End Management Investment Companies.
Item 11: Statement Regarding Basis for Approval of Investment Advisory Contract
(Unaudited)
Board Approval of Investment Advisory Contracts and Management Fees
Fidelity Nasdaq Composite Index ETF
At its May 2026 meeting, the Board of Trustees, including the Independent Trustees (together, the Board), voted to continue the management contract with Fidelity Management & Research Company LLC (FMR), and the sub-advisory agreements and sub-subadvisory agreements, in each case, where applicable (together, the Advisory Contracts) for the fund, including the fund's sub-advisory agreement with Geode Capital Management, LLC, for two months from June 1, 2026 through July 31, 2026. The Board determined that it will consider the annual renewal of the fund's Advisory Contracts for a full one year period in July 2026, following its review of additional materials provided by FMR.
The Board considered that the approval of the fund's Advisory Contracts will not result in any changes in (i) the investment process or strategies employed in the management of the fund's assets; (ii) the fees and expenses paid by shareholders; (iii) the nature, extent or quality of services provided under the fund's Advisory Contracts; or (iv) the day-to-day management of the fund or the persons primarily responsible for such management. The Board also considered that since its last approval of the fund's Advisory Contracts, FMR had provided additional information on the fund in support of the annual contract renewal process, including competitive analyses on total expenses and management fees and in-depth reviews of fund performance and fund profitability information. The Board concluded that the fund's Advisory Contracts are fair and reasonable, and that the fund's Advisory Contracts should be renewed, without modification, through July 31, 2026, with the understanding that the Board will consider the annual renewal for a full one year period in July 2026.
In connection with its consideration of future renewals of the fund's Advisory Contracts, the Board will consider: (i) the nature, extent and quality of services provided to the fund, including shareholder and administrative services and investment performance; (ii) the competitiveness of the management fee and total expenses for the fund; (iii) the costs of the services and profitability, including the revenues earned and the expenses incurred in conducting the business of developing, marketing, distributing, managing, administering, and servicing the fund and its shareholders, to the extent applicable; and (iv) whether there have been economies of scale in respect of the Fidelity funds, whether the Fidelity funds (including the fund) have appropriately benefited from any such economies of scale, and whether there is the potential for realization of any further economies.
Based on its evaluation of all of the conclusions noted above, and after considering all factors it believed relevant, the Board, including the Independent Trustees, ultimately concluded that the fund's management fee structure is fair and reasonable, and that the continuation of the fund's Advisory Contracts should be approved for two months from June 1, 2026 through July 31, 2026.
1.795572.122
ETF-SANN-0726

Item 8.

Changes in and Disagreements with Accountants for Open-End Management Investment Companies

See Item 7.

Item 9.

Proxy Disclosures for Open-End Management Investment Companies

See Item 7.

Item 10.

Remuneration Paid to Directors, Officers, and Others of Open-End Management Investment Companies

See Item 7.

Item 11.

Statement Regarding Basis for Approval of Investment Advisory Contract

See Item 7.

Item 12.

Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies

Not applicable.

Item 13.

Portfolio Managers of Closed-End Management Investment Companies

Not applicable.

Item 14.

Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers

Not applicable.

Item 15.

Submission of Matters to a Vote of Security Holders

There were no material changes to the procedures by which shareholders may recommend nominees to the Fidelity Commonwealth Trust’s Board of Trustees.

Item 16.

Controls and Procedures

(a)(i) The President and Treasurer and the Chief Financial Officer have concluded that the Fidelity Commonwealth Trust’s (the “Trust”) disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act) provide reasonable assurances that material information relating to the Trust is made known to them by the appropriate persons, based on their evaluation of these controls and procedures as of a date within 90 days of the filing date of this report.

(a)(ii) There was no change in the Trust’s internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act) that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the Trust’s internal control over financial reporting.

Item 17.

Disclosure of Securities Lending Activities for Closed-End Management Investment Companies

Not applicable.

Item 18.

Recovery of Erroneously Awarded Compensation

(a)

Not applicable.

(b)

Not applicable.

Item 19.

Exhibits

(a)

(1)

Not applicable.

(a)

(2)

(a)

(3)

Not applicable.

(b)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Fidelity Commonwealth Trust

By:

/s/Stacie M. Smith

Stacie M. Smith

President and Treasurer (Principal Executive Officer)

Date:

July 23, 2026

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

By:

/s/Stacie M. Smith

Stacie M. Smith

President and Treasurer (Principal Executive Officer)

Date:

July 23, 2026

By:

/s/Stephanie Caron

Stephanie Caron

Chief Financial Officer (Principal Financial Officer)

Date:

July 23, 2026

Fidelity Commonwealth Trust published this content on July 23, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on July 23, 2026 at 14:46 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]